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anti-CAT antibody to CAT
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DOPE dioleoyl phosphatidylethanolamine
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DOT AP N - [ 1 -(2,3-Dioleoyloxy)propyl] -N,N,N-
trimethylammonium methylsulphate 
EDTA Ethylenediaminetetra-acetic acid
EGF Epidermal growth factor
EGTA Ethylene glycol bis (P-aminoethyl ether)
N ,N ,N \N ’-tetra-acetic acid 
ELISA Enzyme-linked immunosorbant assay
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FSB Frozen storage buffer
g gram
HAC0CI3 Hexamine cobalt chloride
HBS Hepes buffered saline
HC1 Hydrochloric acid
Hepes (N-(2-Hydroxyethyl)piperazine-N-(2-ethane
sulphonic acid) 
hr hour
KAc Potassium acetate
Kbp kilo base pairs
KC1 Potassium chloride
kDa kilo Dalton
kV kilo volts
K3Fe(CN)g Potassium ferricyanide
K4Fe(CN )6 Poassium ferrocyanide
LB liquid broth
M  Molar
mA milli amps
mg milligram
M gATP Magnesium adenosine triphosphate
M gCl2 Magnesium chloride
M gS04  Magnesium sulphate
min minute
m l millilitre
m M  millimolar
M M P matrix metalloproteinases
M nCM H aO  M anganese chloride tetrahydrate
msec millisecond
Na2HPC>4 di-Sodium phosphate anhydrous
NaH 2PC>4 Sodium dihydrate phosphate
N.D. N ot determined
N.S. N ot suitable
NaAc Sodium acetate
NaCl Sodium chloride
NaOH Sodium hydroxide
ng nanogram
nM  nanomolar
O.D. Optical Density
PBS Phosphate buffered saline
pg picrogram
POD peroxidase
rpm  revolutions per minute
RT room  temperature
s second
SBX sucrose bromophenol blue xylene cyanol
SCID severe combined im munodeficient
SDS sodium dodecyl sulphate
SV-40 simian virus 40
TBE Tris-boric acid-EDTA
TBS Tris buffered saline
TE Tris-EDTA
TEN Tris-EDTA-NaCl
TF Transcription factor
TFUA Trancription factor IIA
TFIIB Transcription factor IIB
i hl i i)  Transcription factor HD
TFHE Transcription factor IIE
TGFp Transforming growth factor P
TIE Transforming growth factor P inhibitory elem ent
TIMP Tissue inhibitors o f metalloproteinases
TORU TPA and oncogene responsive unit
TPA 1 2 -O-tetradecanoy 1-phorbol-13 -acetate
TRE TPA responsive element
TRIS T ris(hydroxymethyl)methylamine
a iP I a i  protease inhibitor
HF micro Farrad
microgram
Ml microlitre
v/v volume per volume
w/w weight per weight
X-gal 5-Bromo-4-chloro-3 indoyl-P-d galactoside
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Chapter 1
Introduction
1.1 . A n  in tro d u c tio n  to  m a tr ily sin  an d  its  fu n ctio n s
Matrilysin is a member of the family of matrix metalloproteinases ( M M Ps ). The 
matrix metalloproteinase family o f enzymes are involved in rem odelling o f the 
extracellular matrix (Gaire et al,  1994). Remodelling of the extracellular matrix is a 
critical event in normal processes such as tissue morphogenesis, differentiation, and 
wound healing, and the matrix metalloproteinases are believed to be key role players 
in these events. In addition, these enzymes are also involved in pathological 
conditions such as tumour invasion, metastasis, and arthritis.
Matrilysin has also been shown to be involved in metabolic pathways that affect the 
activity of proteases that act on the extracellular matrix. Crabbe et al., (1994) showed 
that human progelatinase A, the inactive form  o f the enzyme, can be activated by 
matrilysin. M atrilysin has also been shown to rapidly inactivate cti-protease inhibitor 
(aiPI), an inhibitor o f elastase, by cleaving the Pro357-Met358 peptide bond in its 
reactive centre. M atrilysin also plays an important role in the inactivation of serpins 
(serine proteinase inhibitors) in malignant tissues, where a cascade of 
metalloproteinases and serine proteinases are required for tissue degradation (Zhang et 
al., 1994).
As a member o f the M MP family, matrilysin plays a key role in metastasis and 
invasion. Malignancy, the potential of a tum our to metastasise, requires invasion. A 
benign tumour, which has no invasive properties, has a definite border. In contrast a 
malignant tumour has a poorly defined border called the invasive front, where 
individual tumour cells migrate away from the primary mass (Liotta et al., 1992). 
Metastasis is a multi-step process. Initially cells detach from the primary malignant 
tumour mass, and move into the blood vessels that nourish it. The first barrier that 
faces the migrating tumour cell, is the layer of endothelial cells that line the interior of 
blood vessels and lymph vessels. It has been demonstrated that tum our cells may 
possess special adhesive affinities for the endothelial surface. The binding of tumour 
cells to the endothelial layer causes it to retract and expose the tissue beneath it.
The barrier beneath the endothelial cells is the extracellular matrix. The matrix is a 
dense meshwork o f diverse proteins and carbohydrate molecules. In mammalian 
organisms, fences of extracellular matrix divide tissues into a series o f compartments.
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One specialised form of the matrix is the basement membrane, which ensheaths the 
blood vessels, muscle cells and nervous system. Adjacent to the basem ent membrane 
is another type o f matrix called the interstitial stroma, which holds other tissue cells 
and lymphatic vessels.
1.1 .2 . P ro p er ties  an d  stru ctu re  o f  m a tr ily sin
So far in humans ten members of the M M P family have been identified and 
characterised, (Table 1.1). The members of the matrix metalloproteinase family that 
have been identified so far, can be divided into at least three subclasses by substrate 
specificity: the type I collagenases degrade fibrillar interstitial collagens; the 
gelatinases recognise basement membrane type IV collagen and denatured collagens; 
and the stromelysins, of which matrilysin is a member, hydrolyse proteoglycans and 
extracellular m atrix glycoproteins. Another member has been added to the matrix 
metalloproteinase family. Sato et al., (1994) identified an M MP that is an integral 
plasma membrane protein. It was the first membrane-type M M P (M T-M MP-1) 
discovered. MT-MMP-1 can activate pro-gelatinase A and so may be the upstream  
activator in the gelatinase A proteolytic cascade.
Matrilysin exhibits a number of functional and structural properties that are typical of 
the matrix metalloproteinase family. It contains a zinc ion and is secreted in a latent 
form that requires activation for proteolytic activity. Activation by autocatalysis does 
not occur unless the propeptide is perturbed and it is thought that in vivo activation 
may arise by propeptide clipping, by protease’s such as plasmin, (Cockett et al., 
1993). Similar to other matrix metalloproteinases, matrilysin is inhibited by specific 
tissue inhibitors of metalloproteinases ( TIM Ps ) (Matrisian 1990, M cDonnell and 
Fingleton 1993).
The members of the matrix metalloproteinase family contain several distinct domains 
that are conserved, (Figure 1.1). Matrilysin has three domains, the pre, pro, and 
catalytic domain. A hemopexin domain is present in the other family members but is 
absent in matrilysin. The predomain is a leader sequence (~ 17 amino acids ), which 
targets the molecule for secretion. It is subsequently removed and is therefore not 
present in the latent enzyme, (W ilhelm et al., 1987). The propeptide domain, (~ 80
2
amino acids) is cleaved when the enzyme is activated. This domain contains the 
highly conserved sequence proline, arginine, cysteine, glycine, valine, asparagine, 
proline, aspartic acid (PRCGV/NPD), (Grant et al,  1987; Stetler-Stevenson et al,  
1989a; Nagase et al., 1990) which is present in all members o f the M M P family. The 
available data suggest that this region is involved in maintaining the enzyme in a 
latent state since mutations in this region result in an enzyme that no longer requires 
proteolytic activation (Matrisian et al., 1991).
In vitro this activation can be achieved by organomercurials, oxidants, sulfhydryl 
alkylating agents and, in some cases, proteolytic cleavage by trypsin or plasmin 
(W ilhelm et al., 1987; Stetler-Stevenson et al., 1989a; He et al., 1989; Springman et 
al., 1990). The third domain, the catalytic domain contains the zinc molecule. 
Activation is thought to occur by an unfolding of the latent enzyme freeing the zinc 
molecule from its binding with the cysteine residue in the conserved PRCGV/NPD 
region, and allowing the zinc atom to be bound by water, (Springman et a l,  1990).
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M a trix -d eg ra d in g  m e ta llo p ro te in a ses  
N a m e L a ten t A ctiv e  D eg ra d es
(kD a) (kD a)
Subclass 1
a. Interstitial collagenase 55 45 Fibrillar
collagens
Gelatin
Proteoglycan
b. Neutrophil collagenase 75 58 As
interstitial
collagenase
c. Collagenase-3 55 54 As 1(b)
Subclass 2
a. Gelatinase-A 72 66 Denatured 
collagens 
Collagen IV, V, 
VII, X 
Elastin
b. Gelatinase-B 92 86 As gelatinase-A
Subclass 3.
a. Stromelysin-1 57 45 Proteoglycan 
Collagen II, IV, 
XI
Gelatins, laminin, 
Fibronectin
b. Stomelysin-2 57 44 As stromelysin-1
c. M atrilysin 28 19 As stromelysin-1
d. Stromelysin-3 51 44 Unknown
e. Elastase 53 22 Elastin
T a b le  1 .1 . P ro p er tie s  o f  h u m a n  m a tr ix  m eta llo p ro te in a ses .
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PRCGVPD
Matrilysin
Stromelysin-1 
Stromelysin-2 
Stromelysin-3 
Interstitial Collagenase 
Neutrophil Collagenase
Gelatinasae A
Gelatinase B
I  Signal Sequence □  Hemopexin Domain
H  Propeptide I  Gelatin Binding Domain
of Fibronectin
□  Catalytic Domain H  Collagen Binding Domain
F ig u re  1 .1  D o m a in  stru c tu re  o f  th e  M M P  fa m ily  m em b ers. All members of the 
M MP family contain at least three protein domains: a predomain encoding the leader 
sequence that targets the enzymes for secretion, a prodomain which is removed when 
the enzyme becomes activated, and the catalytic domain which contains the zinc 
binding region.
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1.1 .3 . T issu e  in h ib ito rs  o f  m eta llo p ro te in a se s  (T IM P s)
TIMPs are a multigene family which at present consists o f three members, TIMP-1, 
TIMP-2 and TIMP-3 (Stetler-Stevensin et al, 1990, Uria et al., 1994). Both TIMP-1 
and TIM P-2 contain 12 cysteine residues at virtually identical positions clearly 
indicating that these two proteins are from the same family. These two proteins bind 
noncovalently to active metalloproteinases in a 1 :1  molar ratio and specifically inhibit 
their enzymatic activity. TIMP-1 is a glycoprotein (Mr 30 kDa) and its cDNA and 
amino acid sequence has been reported (Docherty et a l,  1985; Carmichael et al., 
1986), although purification and characterisation of the protein from rabbit bone tissue 
had earlier been achieved by Cawston (1981), and others (Welgus and Stricklin, 1983; 
Murphy et al., 1981).
Early studies investigating the link between TIMP-1 expression and invasive ability in 
cell line models, showed that TIMP-1 levels were decreased 10-20 fold in highly 
invasive cells as compared to the level in normal or poorly invasive cells (Hicks et al, 
1984). The second member of the TIM P family, TEMP-2 is a nonglycosylated protein 
(Mr 23 kDa) which was isolated and cloned more recently by several different groups 
(DeClerck et a l,  1989; Goldberg et a l,  1989; Stetler-Stevenson et a l,  1989b; Boone 
et al, 1990). The activity o f TIMP-2 has also been well characterised. It reacts 
stoichiometrically with active interstitial collagenase and also prevents the activation 
of this enzyme from its 52 kDa proform to 42 kDa active form (DeClerck et al, 
1991). It is thought that the TIMP-2 prevents autocatalytic activation of gelatinase-A 
(Howard et a l,  1991), and probably works in a similar fashion with matrilysin. A 
more recent article has a different opinion on matrilysin being inhibited by TIMPs, 
and suggests, that matrilysin resists inhibition by TIM P in vivo, as it lacks the C- 
terminal domain which contributes to the binding of TIMP, (Baragi et al., 1994). 
TIMP-3 displays low sequence similarity to the TIMP-1 and TIM P-2 but shows a high 
degree of of similarity with chicken inhibitor of metalloproteinase 3. The latter is a 
recently described metalloproteinase inhibitor stimulated during oncogenic 
transformation of chicken fibroblasts and with the ability to promote some phenotypic 
properties of transformed cells (Uria et al,  1994).
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1.1 .4 . E x p r ess io n  o f  m a tr ily sin
M atrilysin mRNA and protein has been observed in a number of human carcinoma 
samples from a variety of tissue types. Initial experiments using Northern Blot 
analysis showed that matrilysin was expressed in 8 of 10  gastric carcinomas and in 6 
of 8 colon carcinomas, (McDonnell et a l,  1991). M atrilysin was not detectable in 
normal adjacent tissue from any o f these patients. In this study, matrilysin was 
localised to the cancerous tissue by in situ hybridisation and immunohistochemistry.
A series of colon lesions ranging from small adenomas to carcinomas, using in situ 
hybridisation and immunohistochemistry were examined in an attempt to establish the 
role o f matrilysin in colorectal tumourigenesis. The initial results suggested that 
matrilysin expression arises in areas of benign adenoma polyps destined to become 
malignant carcinomas, (Newell et a l,  1993). These results supported the hypothesis 
that matrilysin expression is a late event in colon carcinogenesis associated with the 
conversion of a benign tumour to a malignant tumour.
As mentioned above, in colorectal cancers matrilysin is produced by cancer cells 
themselves, while other MMPs, are produced by stromal cells (Pyke et al., 1993). 
This suggests that matrilysin may directly contribute to invasion of colon cancer cells. 
Yamamoto et al., (1995), modulated the expression of matrilysin in colon cancer cells 
by introducing both sense and anti-sense matrilysin and tested the effects of this 
modulation on the ability of colon cancer cells to migrate across an artificial 
membrane in vitro. They found that the introduction of matrilysin into a colon cancer 
cell line that did not express matrilysin caused these cells to becom e more invasive as 
assessed by an in vitro invasion assay.
M atrilysin has also been shown to play a role in prostate cancer. Pajouh (1991) 
showed that 14 of 18 prostate adenocarcinomas and 3 of 11 normal prostate tissue 
samples express matrilysin. A human prostate cancer cell line, which does not 
normally express matrilysin was transfected with a plasmid containing the full-length 
matrilysin cDNA. After intraperitoneal injection into severe combined 
immunodeficient (SCID) mice, the matrilysin transfected cell lines were observed to 
invade through the diaphragm more effectively than control transfected cell lines,
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(Powell et al., 1993). M atrilysin expression has also been detected in both benign and 
m alignant breast tumour samples (Basset et al., 1990).
M uller et al., (1991) investigated the presence o f matrilysin m RN A  in head and neck 
tumours and in lung tumours. High levels o f matrilysin mRNA were detected in 45% 
o f head and neck squamous cell carcinoma samples. M atrilysin mRNA could be 
detected in nearly all types o f lung cancer except for in a fibrosarcom a sample. 60% 
of normal bronchial mucosa samples analysed displayed detectable levels of 
matrilysin mRNA. High levels o f matrilysin mRNA were detected in 62% of the lung 
squamous-cell carcinoma samples analysed. Also matrilysin mRNA overexpression 
was detected in primary lung adenocarcinomas.
Despite this wealth of data documenting matrilysin expression in numerous processes, 
little is known of the mechanisms regulating its expression. The aim of this project 
was to examine the regulation of matrilysin expression at the transcriptional level. 
This information could lead to the design of more effective therapeutic agents to 
reduce the incidence of metastatic cancer and other tissue degenerative disorders like 
rheumatoid arthritis.
1.2. Regulation of transcription
Genes primarily have two functions; to be duplicated and to be transcribed. 
D uplication of the genome is necessary if  the genetic inform ation o f a species is to 
pass from one generation to the next. In order though, for this genetic information to 
perform its task it has to be interpreted. Transcription is the name given to the 
interpretation of the genetic code. During transcription, RNA that is complimentary 
to a segment of DNA is formed. As with DNA, RNA has a definite orientation, a 5' 
end and a 3' end, due to the ester linkages between the phosphate and the sugar. The 
polarity of the RNA formed in transcription is just the opposite of that of the DNA 
template on which it was assembled. It is the 3'-5' chain of the DNA double helix that 
is transcribed to form the messenger RNA. Thus the mRNA that is formed during 
transcription holds identical information to that in the 5'-3' chain of the DNA double 
helix.
The ultimate aim o f this project was to elucidate the mechanisms which control the 
transcription of the matrilysin gene. All genes have promoters. This is the control 
element of a gene. The promoter is regulated by a variety o f factors that determine 
w hether or not a gene is switched on or transcribed. Transcription takes place with 
the aid of RNA polymerases. In eukaryotes, three distinct types of RNA polymerase 
are found in the nucleus of the cell. One o f these, RNA polymerase 1, is confined to 
the nucleolus and is concerned exclusively with the synthesis o f the major classes of 
RNA of the ribosome. The other two species of the enzyme occur in the nuclear 
cytoplasm. RNA polymerase 2, is responsible for the formation of mRNA transcripts 
from all the various kinds of structural genes coding for polypeptides. RNA 
polymerase 3, is reserved for certain other small RNA molecules, such as the smallest 
RNA molecule of the ribosome.
These three polymerases are unable by themselves to recognise and bind to specific 
base sequences in promoters. The initiation of transcription depends entirely on 
molecules known as transcription factors. These factors recognise specific sequences 
in promoters that act to initiate transcription. Transcription factors are diffusible 
proteins that affect expression o f unlinked genes, thus they are frequently referred to 
as trans-acting factors. Regulatory sequences, on the other hand, that control
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transcription of adjacent genes are referred to as cis-acting elements. The ds-acting  
regulatory sequences of a number of genes have been identified and were found to 
contain binding sites for factors that activate transcription.
Almost all promoters that interact with RNA polymerase 2, contain a conserved 
sequence know as the Hogness box, or more commonly, the TATA box. This 
sequence, found about 15-30 bases upstream from +1 , the start site of transcription, 
has the characteristic consensus sequence TATAAAA. Investigations have revealed 
that four different transcription factors bind in the vicinity o f the TATA box. One of 
these transcription factors 11D (TF11D) , which is known as the TATA protein, 
actually recognises the TATA sequence and must bind to the DNA before any other 
molecule can do so. Once TF1 ID  binds, it is then followed in a specific order by the 
binding of, transcription factors TFIIA, then T H 1B, the RNA polymerase, and finally 
TF11E. TF11D is thought to be an essential part of the general mechanism that 
stimulates transcription in eukaryotic cells, since the TATA sequence is found in m ost 
RNA polymerase 2 promoters.
The TATA sequence often works in conjunction with another sequence known as the 
CAAT box, which has the characteristic consensus GGCCAATCT, and is usually 
located further upstream in the promoter.
Other sequences have also been identified that affect eukaryotic transcription. These 
include two GC boxes, each of which contain the sequence GGGCGG. One such box 
is usually found upstream and one downstream from the CAAT box in m ost 
polymerase 2 promoters.
The transcription factors which affect these regulatory sequences in the promoter, can 
either have a repressive or a facilitative nature depending on the transcription factor. 
DNA sequences known as enhancers can greatly influence transcription. An enhancer 
can increase the rate of transcription from some promoters as much as 200 times. The 
enhancer element is unusual in that it can exert its effect on a initiation site even 10  kb 
upstream  or downstream and may even be found within the coding region o f the gene 
itself.
The promoter region of the gene is not transcribed to form  part o f the mRNA 
transcript. Transcription begins past the promoter region designated as +1. All 
sequences in the 5 '-flanking region of the start site that is in the promoter, are
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designated a minus number. It is in this region that the various transcription factors 
regulating the transcriptional process bind. Figure 1.2.1. further elucidates this 
process.
The final product of transcription of a gene is the mRNA for that gene. It is from the 
mRNA that the protein for which the gene/DNA coded for, is made at a site on the 
ribosome. The mRNA contains a segment at its 5' end called the leader. The leader is 
not translated by the ribosome, as it does not code for inform ation that designates the 
amino acid sequence in a polypeptide. The leader sequence is involved in the binding 
of the mRNA to the ribosome so that translation of the nucleotide sequences that do 
code for amino acids can take place properly. The codon in the mRNA that usually 
designates where translation is to begin is AUG. The sequence of the transcript that 
codes for the amino acid sequence of a polypeptide is found in that part o f the mRNA 
between the leader and trailer. This trailer sequence like the leader is not translated. 
A chain terminating codon ( UAG, UGA or U A A ) signals the end o f translation. The 
trailer is any sequence at the 3' end of the mRNA that follows a chain terminating 
codon, (Rothwell 1993).
Thus, with these basic fundamentals of transcription discussed a closer look at how 
transcription can be induced to take place, and the role that growth factors have in this 
process, will be examined.
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Figure 1.2.1. Features of the transcriptional control region for a mammalian 
protein-coding gene. T h is  is a hypothe tica l array o f  elem ents that constitu te  a 
p rom o te r o f  a gene transcribed by  p o l IE. P rote ins tha t assemble at these co n tro l 
reg ions are sym b o lica lly  represented and inc lude  p o l n ,  TF1 IA , T F IIB , and T F U D , o f 
the general transcrip tiona l m ach inery and various D N A  b in d in g  pro te ins (Jun, Fos and 
P E A 3), that activate th rough  spec ific  elements. The  fig u re  is  no t m eant to  im p ly  tha t 
a ll the D N A  b in d in g  factors m ust be bound s im ultaneously as depicted here in  order 
to  in itia te  transcrip tion .
T A T A
tfiiaYtfixb
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1.2.1. Growth factors and the nuclear response
G ro w th  factors exert the ir b io lo g ica l effects on ce lls  by in te rac tion  w ith  spec ific  ce ll 
surface receptors lead ing  to  the ac tiva tion  o f  a num ber o f  possib le  s ignal transduction  
pathways. The endpo in t o f  g row th  fac to r action  resides in  the regu la tion  o f  gene 
expression. A c tiv a tio n  o f  gene expression by  g ro w th  fac to r-m ed ia ted  signals has a 
num ber o f  characteris tic  features. A  spec ific  subset o f  genes are activa ted or 
repressed and the exact set (o r com b ina tion ) o f  genes responsive to  any g ro w th  fac to r 
is h ig h ly  in fluenced  b y  the id e n tity  o f  the responding ce ll.
There are n o w  a considerable num ber o f  genes w h ich  are kn o w n  to  be 
tra nsc rip tiona lly  activated in  quiescent ce lls a fte r exposure to  a g ro w th  fac to r signal. 
Table 1.2.1. lis ts  a sm all p ropo rtion  o f  these. W h ils t  some genes lis te d  in  th is  table 
can be c lea rly  im p lica te d  in  the process o f  D N A  synthesis (such as nuc leo tide  
m etabo lism  enzymes o r h istones), a considerable p ro p o rtio n  o f  these genes appear to  
have a b io lo g ica l fu n c tio n  unrelated to  the processes o f  m itogenesis. F o r exam ple, 
represented am ongst the set o f  g ro w th -fa c to r-in d u c ib le  genes are several secreted 
ex trace llu la r proteases and ex trace llu la r m a tr ix  com ponents. T h is  illus tra tes  the p o in t 
tha t g row th  factors have m any im portan t b io lo g ica l e ffects on ce ll fu n c tio n  aside fro m  
the in d u c tio n  o f  D N A  synthesis. Th is type o f  response, (i.e. in d u c tio n  o f  genes cod ing  
fo r  ex trace llu la r protease and pro te ins), to  s tim u la tio n  by  g row th  factors has been 
show n to  be c e ll type specific . M any g ro w th -fa c to r in d u c ib le  genes can be induced in  
responsive ce lls by  a va rie ty  o f  d iffe re n t g row th  factors as w e ll as pha rm aco log ica l 
m itogens such as pho rbo l esters, e.g. 12-O -te tradecanoyl-phorbo l 13-acetate (T P A ).
I t  can be concluded that the in d u c tio n  o f  gene expression by g row th  factors in vo lve s  a 
select group o f  genes, representing a w ide  va rie ty  o f  b iochem ica l func tions  whose 
expression is o ften  subject to  some fo rm  o f  ce ll-type  spec ific  p rogram m ing.
Gene expression is regulated in  a cascade lik e  fash ion. In  th is  cascade o f  gene 
ac tiva tion  as a resu lt o f  s tim u la tion  w ith  a g row th  facto r, some genes are expressed 
ra p id ly  in  response to  receptor-m ediated s igna lling . Some o f  these genes are in v o lv e d  
in  the transcrip tiona l ac tiva tion  o f  the in term edia te  class o f  genes activated. A  
num ber o f  the genes activated in  th is in term edia te  step are in vo lve d  in  the late class o f  
gene activa tion .
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Early genes Function
c-fos —
K ro x -2 0
K ro x -2 4 T ra n sc rip tio n  factors
Fra-1
c-myc
Intermediate genes
collagenase M eta llop ro te inase
JE C ytok ine
Cathepsin L Protease
O steopontin E x tra ce llu la r m a tr ix  p ro te in
F ib ronec tin E x tra ce llu la r m a trix  p ro te in
T IM P Protease in h ib ito r
Late genes
D ih yd ro fo la te  reductase N uc leo tide  m e tabo lism
H istone H 4 C hrom atin  structure
T h ym id in e  kinase N uc leo tide  m etabo lism
Table 1.2.1. Some examples of growth-factor inducible genes
Th is  m ode l o f  cascade regu la tion  has been investiga ted in  several ways. A m o n g s t the 
m ost f ru it fu l approaches has been the analysis o f  cLv-acting transcrip tiona l regu la to ry
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elements requ ired  fo r  in term edia te  gene expression. A n  exam ple o f  an in te rm ed ia te  
gene, is the secreted m eta lloprote inase collagenase, whose expression can be induced 
in  quiescent fib rob las ts  by  a va rie ty  o f  g row th  factors as w e ll as p h o rb o l esters such as 
T P A . A na lys is  o f  sequences present in  the collagenase p rom ote r, requ ired  fo r  
transcrip tiona l ac tiva tion  by T P A , lead to  the d iscovery o f  an 8 base p a ir  (bp) segment 
o f  D N A  (term ed the T R E  o r T P A  responsive e lem ent), w h ic h  cou ld  con fe r in d u c tio n , 
(w ith  in te rm ed ia te  t im in g  characteristics), by  T P A  (o r g ro w th  factors such as 
ep iderm al g row th  fac to r -E G F) on a heterologous gene. In  o ther w o rds  the T R E  
behaves as an in d u c ib le  enhancer (A n g e l et al., 1987). Enhancers are D N A  sequences 
that can greatly  increase the rate o f  transcrip tion  o f  genes and whose in flu e n ce  can be 
fe lt  fa r upstream  o f  fa r downstream  fro m  the p rom oters they stim ulate.
M any  g ro w th -fa c to r in d u c ib le  genes w ith  in term edia te  t im in g  characteris tics con ta in  
iden tica l o r re la ted sequences w ith in  th e ir  genetic regu la to ry  elements. T h is  suggests 
tha t ac tiva tion  o f  m any in term edia te  genes invo lves  a m o lecu la r species w h ic h  
interacts, in  a sequence-specific m anner, w ith  the T R E  (o r re lated sequences), whose 
fu n c tio n  is to  induce transcrip tion  o f  the target gene. A  va rie ty  o f  d iffe re n t techn ica l 
approaches le d  to  the id e n tifica tio n  and characterisation o f  th is  m o lecu la r species (o r 
transcrip tiona l ac tiva to r) responsible fo r  TR E-dependent g row th -fac to r-m ed ia ted  gene 
expression. T h is  p roved  to  be a com p lex  o f  tw o  pro te ins Fos and Jun, the products  o f  
the oncogenes c-fos and c-jun, w h ich  act by b in d in g  d ire c tly  to  the T R E  and c lose ly  
re lated sequences, (C urran et al., 1989, Rauscher et al., 1988).
Fos and Jun in te rac t to  fo rm  a transcrip tion  com p lex  by  means o f  a p ro te in  structu ra l 
m o t if  term ed a “ leuc ine  z ipper” . T h is  is created b y  an a -h e lica l dom a in  con ta in in g  a 
regu lar spacing o f  leucine residues on one face o f  the h e lix . The leuc ine  residues, in  
association w ith  spec ific  surround ing am ino acids, p e rm it the tw o  m olecu les to 
d im erize  creating the sequence-specific D N A -b in d in g  dom ain  (K oudarides et al., 
1988). A  va rie ty  o f  evidence demonstrates tha t sequence-specific b in d in g  o f  the 
fos /jun  d im er in itia tes  gene transcrip tion  and perhaps the m ost co m p e llin g  evidence is 
that Fos/Jun-m ediated TR E-dependent transcrip tion  is abolished upon m u ta tio n  o f  the 
leucine z ipper dom a in  o f  e ither partner.
T h is  discussion o f  the e ffec t that g row th  factors have on the nuclear response is no t a 
com plete one as the w ho le  p ic tu re  o f  every pathw ay in  th is com p lex  series o f  events
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has no t yet been fu l ly  e lucidated. H a v in g  discussed the basic fundam enta ls o f  
transcrip tion  and how  the transcrip tiona l process can be induced b y  g ro w th  factors the 
fo llo w in g  section exam ines the m a tr ily s in  prom oter.
1.3. Sequence analysis of the matrilysin promoter
4.2 K b p  o f  the m a tr ily s in  p rom ote r has been iso la ted and up to  933 bp has been 
sequenced (G aire  et al., 1994). F igure  1.3.1. ou tlines a schem atic representa tion o f  
the m a tr ily s in  prom oter.
5 ’ - f la n k in g  reg ion  C od ing
-4.2 +1 reg ion
*
f T IE PEA3 P EA3 A P -11 T A T A ATG
-475 -170 -146 -67 -32
Figure 1.3.1. Regulatory sequences present in the matrilysin promoter. T h is  
d iagram  illus tra tes  the regu la tory sequences present in  the m a tr ily s in  p rom ote r. As 
can be seen a T A T A  box , an AP-1 m o tif, tw o  P E A 3 m o tifs  and a T IE  m o t if  are 
present. There are also tw o  m ore T IE  elements located fu rth e r upstream  at pos itions  - 
500 and -820. The sequence A T G  is  the codon tha t designates w here transcrip tion  
begins and + 1  s ign ifies  the start site o f  transcrip tion .
A na lys is  o f  the 5 '-fla n k in g  reg ion  revealed a T A T A  bo x  at pos itions  -32  to  -25, 
centred at p o s itio n  -30. T h is  fin d in g  supported the id e n tific a tio n  o f  the nuc leo tide  
ind ica ted  at +1 as the ca tabolite  ac tiva to r p ro te in  (C A P ) site. I t  has been fo u n d  that 
fo r  fu l l  transcrip tion  o f  certa in genes to  occur in  E.coli , tw o  factors are necessary. 
One is a s im p le  m olecu le , cyc lic  adenosine m onophosphate (c A M P ) fo rm ed  fro m  
A T P . Th is  sm a ll c A M P  m olecu le  has been designated the second messenger because 
o f  its  in teractions, w ith  horm ones in  th e ir  co n tro l o f  ce ll a c tiv ity . c A M P  does no t 
s tim ula te  transcrip tion  d irec tly . I t  m ust activate a spec ific  ce ll p ro te in , the C A P .
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W hen  C A P  is activa ted by c A M P  the C A P -c A M P  com p lex  b inds d ire c tly  to  the D N A . 
The action o f  the C A P -c A M P  com p lex  is no t com p le te ly  know n . The b in d in g  o f  the 
com p lex  is though t to destabilise the D N A  in  the T A T A  b o x  reg ion , causing i t  to  
denature and open up. In  prom oters tha t requ ire  C A P -c A M P , the R N A  po lym erase is 
unable to  achieve th is  denaturation and cannot proceed w ith  transc rip tion  w ith o u t the 
C A P -c A M P  com plex.
The m a tr ily s in  p rom ote r contains an A P -1  m o t if  between pos itions  -67 and -61. The 
pos itions o f  the T A T A  box  and A P - 1 site in  the m a tr ily s in  p rom o te r are ve ry  s im ila r 
to those seen in  hum an in te rs tit ia l collagenase, s trom elys in , s trom e lys in - 2  and rat 
s trom elys in  and strom elys in -2 , (G aire et al., 1994). The A P -1  m o t if  is  kn o w n  to 
con fe r responsiveness to  a va rie ty  o f  oncogenes, g ro w th  factors and tum ou r prom oters 
and is recognised b y  a transcrip tiona l com p lex  com posed o f  m em bers o f  the c-fos and 
c-jun fam ilie s . The AP -1 m o tif, is also kn o w n  as the T R E  (T P A  responsive e lem ent). 
The p rom ote r also contains tw o  inve rted  P E A 3 elem ents, upstream  to  the A P -1  m o tif ,  
re la tive  to  the consensus sequence (C /G ) A G G A A G  (T /C ). The sequences that are 
observed are C T C C T T C A  and G T C C T T C G . The P E A 3  m o tif, f irs t recognised in  the 
po lyom a v im s  enhancer, is  also an oncogene, g row th  fac to r and p h o rb o l ester- 
responsive e lem ent. The P E A 3 m o t if  can also serve as a b in d in g  site fo r  the products 
o f  the ets oncogene fa m ily . PE A 3  b inds to  the PE A 3  m o tif. PE A 3  is  a transc rip tion  
fac to r w h ich  b inds to  the po lyom a v iru s  enhancer and whose a c tiv ity  is regulated by 
the expression o f  a num ber o f  oncogenes..
G utm an et al., (1990) carried out investiga tions to  establish w hether PE A 3  p layed a 
ro le  in  the in d u c tio n  o f  the collagenase p rom ote r by oncogenes. A  p o in t m u ta tion  in  
the P E A 3 m o t if  was found  to  reduce the le ve l o f  transcrip tion  b y  T P A  and oncogenes 
in  the P E A 3 and A P -1  area, b y  15-27 % o f  the w ild type . T h is  suggested tha t the 
P E A 3 e lem ent in  the collagenase p rom ote r p layed a ro le  in  the in d u c tio n  o f  th is  
p rom ote r by  oncogenes.
M u ta tio n s  in  the AP-1 m o t if  o f  the hum an collagenase p rom ote r com p le te ly  abolished 
the in d u c ib ility  by T P A  o f  the m in im a l collagenase prom oter, w h ich  encompassed the 
AP -1 and P E A 3 m o tifs . These results led  to  the d e fin itio n  o f  a T P A  and oncogene 
responsive (T O R U ) u n it in  the collagenase p rom o te r com posed o f  the tw o  d iffe re n t 
bu t in te rac ting  elements PE A 3  and A P -1 . I t  is possib le tha t the P E A 3  m o t if  acts
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syne rg is tica lly  w ith  the AP-1 m o t if  in  hum an prom oters, to  achieve m a x im a l leve ls  o f  
transcrip tiona l activa tion , (G utm an et al., 1990).
The m a tr ily s in  p rom o te r contains sequences at pos itions -475, -500  and -820  w ith  a 
h ig h  hom o logy  to  the trans fo rm ing  g ro w th -p i (T G F -|3 l), in h ib ito ry  e lem ent, (T IE ), 
w h ich  was o r ig in a lly  id e n tifie d  in  the ra t strom elysin-1 p rom oter, (K e rr  et al., 1990). 
A  suppressive e ffec t o f  TG F-(3 l on m a tr ily s in  gene expression in  the c y c lin g  hum an 
endom etrium  has been observed (B rune r et al., 1995). T G F -p l in h ib its  the EGF, v- 
src and H-ras in d u c tio n  o f  s trom elys in  at the leve l o f  transcrip tion . I t  was found  tha t 
a 10 bp e lem ent in  the strom elys in  p rom ote r was requ ired  fo r  the T G F -P l in h ib ito ry  
effects. The T IE  spec ifica lly  b inds a nuclear p ro te in  co m p le x  fro m  T G F -p i 
s tim u la ted  ra t fib rob lasts . T h is  com p lex  conta ined the c-fos p ro tooncogene product, 
Fos, and in d u c tio n  o f  Fos expression was requ ired fo r  the in h ib ito ry  e ffec t o f  T G F -p i 
on s trom elys in  gene expression. These results led  to  the pos tu la tion  tha t T G F -p i 
in h ib it io n  o f  gene expression is  m ediated by the b in d in g  o f  a Fos-con ta in ing  p ro te in  
com p lex  to  the T IE  prom oter sequences.
The b in d in g  o f  Fos to the T IE  raised the p o ss ib ility  that the T IE  m ay con ta in  A P -1 
b in d in g  s ite -like  sequences, lik e  those found  in  the T R E . A lth o u g h  there are 
s im ila ritie s  in  the prote ins tha t b in d  to  the T IE  and TR E , i t  is though t tha t i t  is  u n lik e ly  
that the T IE  d ire c tly  m im ics  the T R E  (K e rr  et al., 1990).
These experim ents carried ou t on o ther m a tr ix  m eta llopro te inase p rom oters  w o u ld  
serve as an experim enta l m odel that investigates the ro le  o f  the regu la to ry  elem ents in  
the m a tr ily s in  prom oter.
1.3.1. Identification of functional elements within promoters
A lth o u g h  sequence analysis has show n the presence o f  various transcrip tion  
regu la to ry  elements w ith in  the m a tr ily s in  prom oter, as yet, no studies have 
dem onstrated fu n c tio n a l a c tiv ity  fo r  any o f  these elements. The id e n tif ic a tio n  o f  
fu n c tio n a l transcrip tion -regu la to ry  sequences is m ost easily achieved b y  attaching 
these pieces o f  D N A  to a m arke r gene whose gene p roduc t is easily assayable 
fo llo w in g  its in tro d u c tio n  in to  the ce lls o f  in terest by transfection . T rans fec tion  is the 
a b ility  o f  ce lls  in  cu ltu re  to take up exogenous D N A . Several m arker genes have been
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successfu lly used fo r th is  purpose, in c lu d in g  the ch lo ram phen ico l acetyltransferase 
(C A T ) gene, the hum an g row th  horm one gene and the luc ife rase  gene. V a rious  
lengths o f  the hum an m a tr ily s in  p rom ote r had already been lin k e d  to  the C A T  gene 
(G aire  et al., 1994). These are illu s tra ted  in  fig u re  1.3.1
-95
lA P -1  I |  T A T A  I rcÀï
P -95H P C A T
-295
|P E A 3  | |  P E A 3 | F Â m I  |T A T A |
P -295H P C A T
-933
| [TT ÏÏ~ | [  PE A 3 1 | P E A 3 1 r ^ l  | T a t a  | [TÂT|
P -933H P C A T
-4 .2
P -4 .2H P C A T
Figure 1.3.1. The human matrilysin promoter constructs, containing various 
lengths of the human matrilysin promoter linked to the CAT gene. CAT
sequences are ind ica ted by  shaded boxes; the transcrip tion  start site is depicted by  
bent arrows; and the re la tive  pos itions o f  the T A T A , A P -1 , P E A 3, and T G F -P l 
in h ib ito ry  (T IE ) elements are boxed. The m ost 5 ’ -nuc leo tide  o f  the p rom ote r 
sequence conta ined in  the construct is ind ica ted  on the d iagram  and in  the name o f  the 
construct.
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1.4. Transfection methods
A  va rie ty  o f  d iffe re n t transfection  methods are ava ilab le , each o f  them  ta rge ting  a 
d iffe re n t means fo r  the D N A  to  traverse the ce llu la r m em brane. C e lls  can undergo a 
transfection  treatm ent so that they trans ien tly  express the fo re ig n  gene. Th is  
expression o f  the gene usua lly  lasts 2-3 days. In  order to  tra n s fo rm  a c e ll lin e  stably, 
o r perm anently , i t  is necessary to  transfect in  a gene tha t codes fo r  resistance to  a 
a n tib io tic  o r chem ica l, a long w ith  the gene o f  in terest. Once the m e d iu m  is 
supplem ented w ith  the a n tib io tic  to  w h ich  resistance has been conferred, the ce ll line  
w i l l  s tab ly in tegra te  the exogenous D N A  random ly  in to  its genome.
1.4.1. DEAE-dextran method
T h is  technique was f irs t developed fo r  assaying the in fe c tiv ity  o f  S V 40  (Kressm an et 
al., 1978), and subsequently was extended to  assay the in fe c t iv ity  o f  po lyo m a  D N A  
(M e lto n  et al., 1979) and p o lio v iru s  R N A  (W ickens et al., 1980).
The d ie thy lam ino e thy l (D E A E )-d e x tra n -D N A  m ix tu re  is so lub le  and no p rec ip ita te  is 
in vo lve d . D E A E -d e x tra n  is p o lyca tion ic , and is though t to  act by  m ed ia ting , the 
p roduc tive  in te rac tion  between negative ly  charged D N A  and com ponents o f  the ce ll 
surface in  endocytosis. Reeves et al., (1985) dem onstrated tha t once p lasm id  D N A  
enters the D E A E -d e x tra n  transfected cells, i t  is ra p id ly  assembled in to  nucleosom e- 
con ta in ing  m in ichrom osom es.
There are a num ber o f  parameters to  be op tim ised  w hen us ing  th is  m ethod w ith  a 
p a rticu la r ce ll line . O f these, the num ber o f  cells, the concentra tion  o f  D N A , and the 
concentra tion  o f  D E A E -dex tran  added to  the d ish are the m ost im po rtan t to  optim ise. 
C e lls  tha t are 30-50%  con fluen t on a d ish  are m ost su itab le fo r  transfection . Several 
investiga to rs  have show n tha t m ost ce ll types that can be transfected using D E A E - 
dextran, w i l l  have a preference fo r  1-10 [ig  D N A /10 cm  d ish  and fo r  100 to  400 (ig  
D E A E -d e x tra n  per m l o f  media.
O ther factors tha t need to  be op tim ised  inc lude  the du ra tion  o f  the incuba tion  o f  the 
transfec tion  m ix tu re  w ith  the cells, the use o f  a d im e thysu lfox id e  (D M S O ) o r g lyce ro l 
shock to  a id  entry o f  the bound D N A  to  the cells and the use o f  ch lo roqu ine  in  the
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post-transfection  media. T reatm ent w ith  ch lo roqu ine  is though t to  reduce degradation 
o f  the endocytosed p lasm id  D N A , (M o rt lo c k  et al., 1993). C h lo roqu in e  is  ex trem e ly  
to x ic  to  ce lls  in  cu ltu re  so its  to x ic  e ffec t has to be c lose ly  m on ito red . D E A E -d e x tra n  
is m ost su itab le  fo r  sm all amounts o f  D N A . I t  is  no t use fu l fo r  p ro d u c tio n  o f  s tab ly 
transfected ce ll lines. D E A E -dex tran  has been used to  rep roduc ib ly  in fe c t 25%  o f  
BSC -1 m onkey ce lls w ith  S im ian  v irus  40 (S V 40) D N A . T h is  resu lt was obta ined  
afte r an 8 hou r exposure to  200 (Xg/ml o f  D E A E -dextran .
1.4.2. Glass bead method of transfection
The in it ia l w o rk  on the use o f  glass beads was carried  ou t by  M c N e il et. al., (1987). 
In  th is  a rtic le  they described the use o f  glass beads to load  m acrom olecu les in to  l iv in g  
cells in  cu ltu re . In  b rie f, the cu ltu re  m ed ium  o f  the ce ll m ono layer is replaced b y  a 
sm all vo lum e  o f  the m acrom olecu le  to  be loaded. Glass beads (75-500 ( im  d iam eter) 
are then sp rink led  onto  the ce lls, agitated and the ce lls  are washed free o f  beads and 
exogenous m acrom olecules, and “ bead -load ing ”  is com pleted. The glass beads are 
though t to  load m acrom olecules by  causing a “ stress”  on the ce lls, p roduc ing  a 
m om entary rupture  in  the ce ll m em brane a llo w in g  the m acrom olecu les to  enter. 
M athew s et al., (1993) carried  ou t experim ents tha t investiga ted  the use o f  glass beads 
to  transfect cells. F irs tly  the glass beads that they used were pretreated before  use. A s  
purchased, the glass beads have been washed in  acid (H yd ro ch lo ric  acid, HC1). These 
acid-w ashed beads were fo u n d  to adhere strong ly  to cells. T o  a lte r bead surface 
properties so as to  render them  less adherent to  cells, the beads w ere washed in  a lk a li 
(4 M  S od ium  hydrox ide , N aO H ). They also investigated a num ber o f  o ther parameters 
that needed to  be optim ised. These inc luded  the e ffec t o f  D N A  concentra tion , the 
con fo rm a tion  o f  the p lasm id  D N A  (superco iled  o r linear), and bead size am ong 
others. The experim enta l results led  them  to  conclude that transfection  e ffic ie n cy  
increases w ith  D N A  concentra tion  bu t reaches a plateau at 50 (Xg/ml. The topo log y  o f  
the D N A  had no s ig n ifica n t e ffect. Beads o f  the largest d iam eter tested (425 ( im ) 
w ere fo u n d  to  be the m ost e ffective . The sm alle r beads w ere found  to  adhere too 
s trong ly  to the cells, and i t  p roved d if f ic u lt  to  rem ove them  w ith  washing. They fo u n d  
the trans ien t transfection  e ffic ie n cy  o f  th is  m ethod to be approx im ate ly  3% .
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1.4.3 Transfection using the CaP04 method
M o s t app lica tions o f  the ca lc iu m  phosphate m ethod o f  D N A  transfec tion  in to  
m am m alian  ce lls u tilis e  the basic procedure o f  G raham  and V a n  der Eb (1973). The 
basic features o f  th is  procedure inc lude  a m ix tu re  o f  D N A  w ith  C a C ^  and sod ium  
phosphate in  bu ffe red  saline, fo rm a tio n  o f  a ca lc iu m  phosphate (C a P 0 4) -D N A  
precip ita te , and incuba tion  w ith  cu ltu red  cells. A fte r  rem ova l o f  the D N A -c o n ta in in g  
m ed ium , a b r ie f incuba tion  w ith  d im e th y l su lfox ide  o r g lyce ro l is usua lly  em ployed to 
enhance D N A  uptake.
L o y te r et al., (1982) have show n that the D N A -c a lc iu m  phosphate com p lex  enters the 
ce lls v ia  tw o  routes, nam ely, b y  endocytosis and d irec t penetra tion . W ith in  a ce ll 
popu la tion  m ost ce lls endocytose the com p lex  bu t o n ly  a m in o r fra c tio n  o f  them  take 
up the D N A  in  a free fo rm . I t  m ay be that the free D N A , b u t no t the endocytosed 
D N A , is m a in ly  responsible fo r  the b io lo g ica l a c tiv ity  o f  the transfected m olecules. 
U n fo rtuna te ly , there is  a w ide  v a r ia b ility  in  the re ce p tiv ity  o f  a g iven  c e ll type to  
transfec tion  by  th is  technique. R eported transient trans fec tion  e ffic ienc ies  us ing  the 
ca lc iu m  phosphate m ethod w ith  p lasm id  D N A  range fro m  <0.1 -50%  o f  ce lls  
expressing the encoded pro te ins, (W ilso n  et al., 1995).
The p rim a ry  factors that in fluence  e ffic ie n cy  o f  CaPCU transfec tion  are f irs t ly ,  the 
am ount o f  D N A  in  the precip ita te , secondly the leng th  o f  tim e  the p rec ip ita te  is le f t  on 
the cells, and f in a lly  the use and du ra tion  o f  g lyce ro l o r D M S O  shock. G enera lly  h ig h  
concentrations o f  D N A  are used, 10-50 |ig . T o ta l D N A  concentra tion  can have a 
dram atic  e ffec t on e ffic ie n cy  o f  uptake o f  D N A  w ith  CaP0 4 -m ediated transfection . 
W ith  some ce ll lines, m ore than 10 to  15 (ig  o f  D N A  added to  a 10-cm  dish, results in  
excessive ce ll death and ve ry  lit t le  uptake o f  D N A . W ith  o ther ce ll lines  i t  is 
necessary to use up to  50 fig  o f  D N A . The op tim a l leng th  o f  tim e  that the p rec ip ita te  
is le f t  on ce lls varies w ith  ce ll type and has to  be op tim ised  fo r  each ce ll type. T h is  
can va ry  fro m  4 to  24 hr. A ls o  the e ffec t o f  using a g lyce ro l o r D M S O  shock has to  be 
investigated. F o r some cells th is  shock causes ce ll death, whereas, fo r  others i t  g reatly  
im proves the le ve l o f  transfection.
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1.4.4. The electoporation method
E lectropora tion , u tilises  the transient app lica tion  o f  a b rie f, h ig h  vo ltage  e lec tric  pulse 
to induce po re -fo rm a tion  on the ce ll surface, (N eum ann et a l, 1982, Potter et al., 1984 
and 1988). O therw ise nonperm eant m olecules d iffuse , o r are e lectrophoresed, in to  the 
ce lls be fo re  the pores re-seal and the ce ll returns to  its  res ting  state. These pores are 
a r t if ic ia lly  made and i t  is in  th is  w ay that e lectropora tion  d iffe rs  fro m  the o ther types 
o f  transfection  m ethods w h ic h  re ly  on natura l ce llu la r pathways such as endocytosis 
(e.g. CaP0 4  o r D E A E -d e x tra n  m ediated transfection) and lip o fe c tio n  w h ich  depends 
on m em brane fus ion.
E lec tropo ra tion  is m ost dependent on the applied e lec tric  f ie ld , and the f ie ld  (E ) is 
re lated to  the vo ltage (V ) and the distance (d) by the equation  E = V /d . O ther factors 
c r it ic a l to  e ffic ie n t transfection  are the b io lo g ica l param eters fo r  each reagent used 
(ce lls , D N A )  and the du ra tion  o f  the e lectric  pulse, (A n  et al., 1982, A nderson  et al., 
1991, Andreason et al., 1988). These factors m ust be fu rth e r considered and 
op tim ised  in  term s o f  the p rac tica l aspects o f  an experim ent. D N A  am ounts in  the 
range o f  10 to 40 | ig  per 106 c e ll upwards w o rk  w e ll.
F ie ld  strength (vo ltage / distance) is related to  (a) the in te re lectrode  distance and the 
app lied  vo ltage w ith  vo ltage  be ing related, by  O h m ’ s law , V = IR , (b) the cu rren t 
generated and (c) the co n d u c tiv ity  o f  the m edia in  w h ic h  ce lls  are treated. Thus, 
anyth ing w h ich  in fluences e ithe r the vo ltage (the set vo ltage, in te rna l resistances o f  
the e lectropora tion  device, the e lectropora tion  m edia ,) o r the distance (cuvette 
con fo rm ation , size o f  the gap between electrodes) w i l l  a ffec t the e lec tric  f ie ld , 
(A nderson et a l, 1991, Andreason et a l, 1988, G logauer et a l,  1992).
The dura tion  o f  the pulse is  re la ted to  the capacitance o f  the e lec tropora tion  device 
and the co n d u c tiv ity  o f  the m ed ia  in  w h ich  cells are treated.
The f ie ld  strength is the m ost im po rtan t variab le  to  op tim ise . I t  is im p o rta n t to  
op tim ise  th is  because, in  some ce ll lines, the curve fo r  e ffic ie n cy  versus, f ie ld  strength 
is a very sharp peak w ith  changes o f  50 to 70 V /c m  decreasing e ffic ie n cy  fro m  50 to 
90% , (Anderson et a l, 1991, Andreason et a l, 1989, P o tte r et al., 1988). M o s t 
m am m alian  ce lls have been e ff ic ie n tly  e lectroporated in  cu ltu re  m edia  at f ie ld
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strengths o f  500 to  1000 V /c m  at capacitances o f  500 o r 960 m ic ro  Farrads ( |lF ). 
H o w e ve r the o p tim u m  fo r  some ce ll lines w i l l  fa ll ou ts ide  these points.
Some investiga to rs have been able to  increase e ffic ie n c y  o f  transfec tion  at one 
capacitance over another (C hu et al., 1987 Jiang et al., 1991). In  th is  case one 
requires a series o f  vo ltage  op tim isa tion  curves fo r  each capacitance tested. 
Capacitance and vo ltage  are no t inve rse -linearly  re lated: i f  one uses a capacitance o f  
25 |iF , an approx im ate ly  tw o -fo ld  h igher e lec tric  f ie ld  w i l l  be requ ired  re la tive  to  
transfection  at 500 o r 960 (iF , (H o llid a y  et al., 1991).
In  conclusion , an approach to  op tim isa tion  o f  e lec tropora tion  fo r  a p a rticu la r ce ll lin e  
in vo lve s  keeping the am ount o f  D N A , the num ber o f  ce lls  and the e lec tropora tion  
m ed ium  constant. The app lied  vo ltage and the capacitance can then be varied, thus, 
resu lting  in  d iffe re n tia l f ie ld  strength and pulse.
1.4.5. Lipofection as a method of transfection
L ip o fe c tio n  is the te rm  used to  describe the use o f  ca tion ic  lip id -m e d ia te d  
transfection , app licab le  fo r  the func tiona l d e live ry  o f  p lasm id  D N A  in to  cu ltu red  cells. 
C a tion ic  vesicles in te ract spontaneously and ra p id ly  w ith  po lyan ions such as D N A , 
resu lting  in  liposom e/po lynuc leo tide  com plexes tha t capture p ra c tica lly  1 0 0 % o f  the 
po lynuc leo tide . The resu lting  p o lyca tion ic  com plexes are taken up by  the an ion ic  
surfaces o f  tissue cu ltu re  cells. The aqueous ca tion ic  l ip id  reagent is m ixe d  w ith  
nuc le ic  acid m olecules and the com plexes are in troduced  in to  cu ltu re  cells.
The ca tion ic  l ip id  and po lynuc leo tide  aggregates tha t fo rm  are s ticky , and can be seen 
to  s tick  to glassware and p lastic . P o lypropylene and glass attract these aggregates 
m ore than po lystyrene. F o r th is  reason po lystyrene  m ix in g  containers are pre ferred. 
O p tim u m  transfection  a c tiv ity  occurs under cond itions  in  w h ich  the net negative 
charge on the po lynuc leo tide  is substantia lly  reduced. The o p tim u m  transfec tion  
a c tiv ity  fo r  D N A  occurs w hen the ra tio  o f  p o s it iv e ly  charged m o la r equ iva lents 
(con tribu ted  by  the ca tion ic  l ip id )  is nearly  equ iva len t to  the num ber o f  m o la r 
equiva lents o f  negative charge con tribu ted  by the po lynuc leo tide , (Fe igner et al., 
1993).
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A  num ber o f  ca tion ic  lip id s , in c lu d in g  Polybrene, L ip o fe c ta m in e  and D O T A P  w ere 
investigated. Polybrene is  a com m erc ia lly  l ip id  ava ilab le  fro m  A ld r ic h . The 
lipo fec tam ine  reagent used was a 3:1 (w /w ) liposom e fo rm u la tio n  o f  the p o lyca tio n ic  
lip id -2 ,3 -d io le y lo x y -N -[2 (s p e rm in e c a rb o x a m id o )e th y l]-N ,N -d im e th y l- l p ropanam in - 
- iu m  trifluo roace ta te  (D O S P A ), and the neutra l l ip id  d io le o y l 
phosphatidy le thano lam ine  (D O P E ) in  m em brane filte re d  w ater, fro m  G ib co /B R L . N - 
[ l- (2 ,3 -D io le o y lo x y )p ro p y l]-N ,N ,N -tr im e th y la m m o n iu m  m ethylsu lpha te  (D O T A P ) is 
a liposom e fo rm u la tio n  ava ilab le  fro m  B oehringe r M annhe im . O f the three lip id s  
used D O T A P . O f the three lip id s  used D O T A P  is the m ore easily  m etabo lised b y  the 
ce lls than the o ther fo rm u la tions  and therefore, less to x ic  to  the cells. I t  also has an 
added advantage in  that i t  can be used w ith  serum  i f  necessary whereas com ponents 
present in  serum  can a ffec t transfection  o f  ce lls  us ing m ost o ther l ip id  fo rm u la tio n s  
(W a lke r et al., 1992). The lip o fe c tio n  procedure is noted fo r  its  s im p lic ity  and 
re p ro d u c ib ility . The o p tim isa tio n  procedure is qu ite  s im ple. The c r it ic a l factors fo r  
op tim isa tion  are the am ount o f  D N A  and l ip id  fo rm u la tio n  used.
1.5. Experimental aims
E G F  and TP  A  have been shown to stim u la te  m a tr ily s in  m R N A  in  tw o  co lo n  
adenocarcinom a ce ll lines, W iD r  and SW 620, w h ic h  endogenously express m a tr ily s in  
(G aire et al., 1994). These ce ll lines were chosen to  carry ou t experim ents to  
investiga te  i f  E G F  and T P A  are transcativated th rough the A P -1 and P E A 3 elem ents 
located in  the m a tr ily s in  prom oter. The approach adopted was to  transfect the hum an 
m a tr ily s in  p rom ote r constructs illu s tra ted  in  fig u re  1.3.1. in to  these ce ll lines and 
stim ula te  w ith  E G F  and T P A . The ce lls once transfected and harvested w o u ld  be 
stim ulated, and C A T  a c tiv ity  analysed using the C A T  E L IS A . I f  the fa c to r be ing  
investigated had a s tim u la to ry  e ffec t on the m a tr ily s in  prom oter, i t  w i l l  activate the 
p rom ote r causing the 3 ’ - f la n k in g  C A T  gene to  be transcribed. The am ount o f  C A T  
p ro te in  produced is d ire c tly  p ropo rtion a l to  the regu la to ry  e ffec t that the p a rticu la r 
fac to r has on the prom oter. W h icheve r construct showed the greatest s tim u la tio n  o f  
the prom oter, tha t is the largest am ount o f  C A T  p roduction , w o u ld  te ll us tha t i t  is  in  
tha t reg ion  o f  the p rom o te r tha t E G F  o r T P A  is exe rting  its  e ffect.
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B efo re  these transfection  experim ents investiga ting  the regu la tion  o f  m a tr ily s in  gene 
expression cou ld  be carried  out in  the S W 620 o r W iD r  ce ll line , the trans fec tion  
cond itions  fo r  these ce ll lines had to  be optim ised. A  num ber o f  m ethods were 
investigated, the deta ils o f  w h ich  were discussed ea rlie r in  sections 1.4.-1.4.5. The 
p lasm id  p C H llO ,  w h ich  codes fo r  the bacteria l p ro te in  (3-galactosidase, was used in  
these transfection  op tim isa tio n  experim ents. T h is  p lasm id  can be transfected in to  
ce lls and its a c tiv ity  assayed e ither co lo u rim e tr ica lly  us ing  the synthe tic  substrate 
ch lo ropheny l red (3-d galactoside (C PR G ) o r in situ b y  s ta in ing  w ith  5 -B ro m o -4 - 
ch lo ro -3  in d o y l-P -d  galactoside (X -ga l). In  th is  w ay, the e ffic ie n cy  o f  va rious 
transfection  m ethods can be estimated. I t  was hoped to  f in d  an e ff ic ie n t means o f  
transfecting  the S W 620 o r W iD r  ce ll line , and then transfect in  the m a tr ily s in  C A T  
p rom o te r constructs and analyse the a c tiv ity  o f  the m a tr ily s in  p rom o te r fo llo w in g  
treatm ent w ith  E G F  and T P A .
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Chapter 2
Materials and Methods
2.1 Materials
M a tr ily s in  p rom ote r C A T  reporter constructs were supp lied  by  P ro f. L y n n  M a tris ia n , 
V a n d e rb ilt U n ive rs ity , N a sh v ille  Tennessee U S A . A l l  g row th  factors and cytok ines 
used were obta ined fro m  B oehringer M annhe im , H annover, G erm any. A l l  re s tr ic tio n  
endonucleases w ere bough t fro m  Promega, Southam pton, U K . L -g lu ta m in e , 
p e n ic illin -s tre p to m yc in  so lutions were purchased fro m  S igm a C hem ica l Co., Poole 
Dorset, England. Foeta l c a lf  serum was obta ined fro m  B io w h itta ke r, V e rv ie rs  
B e lg ium . C e ll cu ltu re  m edia  was purchased fro m  G ib co  B R L  U xb ridge , M id d le se x , 
England. C e ll cu ltu re  p lastics and vessels w ere obta ined fro m  Costar, C am bridge, 
M A , 02140, U S A . C hem ica ls were o f  A n a la r grade and w ere purchased fro m  S igm a 
C hem ica l Co., B D H  C hem icals L td ., and M e rck , Poole, D orset, England.
C e ll lines used in  the course o f  th is w o rk  are lis te d  in  Tab le  2.1.1.
D eta ils  o f  spec ific  k its  are lis ted  in  Tables 2.1.2.
D eta ils  o f  p lasm ids used are ou tlined  in  table 2.1.3.
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Cell
Line
Cell type Cat. No. Source
S W 480 H um an co lon  
adenocarcinom a
C C L  228 European
C o lle c tio n
o f  A n im a l C e ll , 
C u ltu res
S W 620 H um an co lon  
adenocarcinom a 
L y m p h  node metastasis
C C L  227 C A M R ,
P orton  D o w n
Salisbury,
W ilts h ire
SP4 O JK  E ng land
W iD R H um an co lon  
adenocarcinom a
C C L  218
A 549 H um an lung  
adenocarcinom a
C C L  185
Table 2.1.1 Cell lines used during the project.
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Materials Supplier
PZ523 D N A  p u r if ic a tio n  k it 5 ’ ------* 3 ’
CP Labora to ries, England.
C A T  E L IS A  k it B oeh ring e r M annhe im  
H annover, G erm any.
B io -R a d  p ro te in  assay k it B io -R a d  Labora to ries 
M u n ich , G erm any
B C A  p ro te in  assay k it P ierce &  W a rrin e r, 
E ng land
H oechst 33258 C alb iochem , B e h ring  
D iagnostics , L a  Jo lla , C A  
92037 U S A .
D O T A P B oehringe r M annhe im  
H annove r G erm any
L ipo fec ta m in e G ib c o /B R L
England
Table 2.1.2. Specific kits and miscellaneous reagents used in the course of the 
work.
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Plasmid Description
p C H llO codes fo r  [3-galactosidase
P -95H P C A T 95 bp o f  the hum an m a tr ily s in  p rom o te r 
lin ke d  to  C A T
P -295H P C A T 295 bp  o f  the hum an m a tr ily s in  p rom ote r 
lin k e d  to C A T
P -933H P C A T 933 bp o f  the hum an m a tr ily s in  p rom o te r 
lin ke d  to C A T
P -4 .2H P C A T 4.2 K b p  o f  the hum an m a tr ily s in  
p rom ote r lin ke d  to  C A T
p F L C A T contains the S V 40  p rom o te r lin k e d  to  the 
3 ’end o f  the C A T  gene, there fo re  the 
C A T  gene is n o t transcribed.
p C M V C A T contains the C M V  p rom o te r lin k e d  to  the 
5 ’ end o f  the C A T  gene, there fo re  the 
C A T  gene is transcribed.
Figure 2.1.3. Plasmids used during the course of this work.
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2.2 Equipment
2.2.1. Centifugation
A  Heraeus C h ris t Labofuge was used fo r  cen trifuga tio n  o f  un ive rsa l tubes (1-25 m l) 
and cen tifuga tion  tubes (1-50 m l). S m alle r vo lum es were cen trifuged  on a Heraeus 
B io fu g e  13 using  eppendorf containers (1-1.5 m l). F o r ce n tr ifu g a tio n  o f  large 
vo lum es (up to  200 m l), at h igher speeds a S o rva ll cen tifuge  was used.
2.2.2. Cell Culture
A sep tic  c e ll cu ltu re  techniques were undertaken in  a H o lte n  L a m in a r A i r  f lo w  cabinet, 
H B  2448. C e lls  were incubated in  a hu m id  5%  C O 2 atmosphere at 37°C in  a Heraus 
incubator.
Lo n g  te rm  storage ce lls were cryopreserved in  a cryoconta iner, (C ooper C ryoserv ice  
L td .)
C e lls  were v isua lised  on an O lym pus C K 2  m icroscope.
2.2.3. Electrophoresis
Electrophoresis was pe rfo rm ed on a H yb a id  ho rizon ta l e lectrophoresis system.
2.3 DNA Preparation methods
2.3.1. Preparation of competent cells
U sing  a sterile  p la tin u m  w ire , E.coli DH5a  w ere  inocu la ted  by  scraping d ire c tly  fro m  
a frozen  stock, (stored at -70°C  in  freez ing  m ed ium ), in to  5 m l o f  SO B, (L iq u id  b ro th  
(L B ), 10g typ tone, 10g S od ium  ch lo ride  (N aC l), 5g yeast extract, w ith  10 m M  
M agnes ium  ch lo ride  (M g C l2) and 10 m M  M agnesium  sulphate (M g S Ü 4)). A  streak 
was also made fro m  the stock onto  SOB and a m p ic illin  plates (35 | ig  a m p ic ill in /m l 
SEB), to  check fo r  con tam ina tion  o f  stock. There shou ld  be no g ro w th  on SOB and
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a m p ic ill in  plates. B o th  plates and liq u id  cu ltures were g row n o ve rn ig h t at 37°C , (150- 
250 rpm ).
1 m l o f  the ove rn igh t cu ltu re  o f  the DH5a, was seeded in to  100 m l o f  SO B. The 
cu ltu re  was inocu la ted  at 37°C  and agitated at 200 rpm  u n til the O .D . at 550 n m  read 
0.45-0.6. O .D . Samples were taken every 20 to  30 m inutes (m in ). The cu ltu re  was 
g row n  fo r  approx im ate ly  2-3 hours (hr).
F o r e ff ic ie n t transfo rm ation , i t  is  essential tha t the num ber o f  v ia b le  ce lls  shou ld  no t 
exceed 108 ce lls /m l. T o  corre late ce ll v ia b il ity  /  num ber to  O .D . at 550 nm , samples 
were taken fro m  a g ro w in g  cu ltu re  o f  E.coli at d iffe re n t tim es in  its  g ro w th  cycle , the 
O .D . at 550nm  read, and d ilu tio n s  o f  these samples were then p la ted ou t on L B  agar 
plates in  the absence o f  an tib io tics .
The cu ltu re  was then cen trifuged at 2,500 rp m  fo r  12 m in  at 4°C. The p e lle t was 
resuspended in  1/3 o f  the vo lum e, 33 m l o f  F rozen storage b u ffe r (F S B ) p H  6.4, (10 
m M  Potassium  acetate (C H 3C O O K ), 100 m M  Potassium  ch lo ride  (KC1), 45 m M  
Manganese ch lo ride  tetrahydrate (M n C l2 4H 2 0 ), 10 m M  C a lc iu m  ch lo rid e  d ihydra te  
(C aC l22 H 2 0 ), 3 m M  H exam ine coba lt ch lo ride  (H A C 0 C I3), 10 % G lyce ro l).
The resuspended p e lle t was le ft  on ice  fo r  10 m in  at 4°C  and then cen trifuged  at 2 ,500 
rp m  fo r  10 m in  at 4°C. The pe lle t was resuspended in  1/12.5 o f  the vo lum e , 8 m l o f  
FSB at 4°C. D M S O  was added to  3.5 % o f  the f in a l vo lum e at 4°C. T h is  was le f t  fo r  
10 m in  at 4°C  and then the same quan tity  o f  D M S O  was added. 200 | l l  a liquo ts were 
prepared in  p re -ch ille d  eppendorfs. These were flash frozen  in  l iq u id  N 2 . The 
com petent ce lls  were subsequently stored at -80°C  fo r  up to  5 m onths.
2.3.2. Transformation of competent cells
10 ng o f  the requ ired  D N A  was a liquo ted  in  a tube. 100 |J,1 o f  com petent ce lls  were 
thawed q u ick ly , and added to  the D N A . The tube was sw ir le d  gently  and p laced on 
ice fo r  30 m in . The tube was then transferred to  a heating b lo c k  at 42°C  fo r  90 
seconds (s). The sample was then p laced on ice fo r  2 m in . 0 .8 m l o f  L B  was then 
added to  the trans fo rm ation  tube. The sample was incubated at 37°C  fo r  1 hr, (225 
rpm ). The transfo rm ed ce lls  were then p la ted  out on a m p ic ill in  plates, (35 | ig /m l) , 
w h ich  w ere incubated at 37°C overn igh t.
32
2.3.3. Minipreparation of plasmid DNA
F rom  the transform ed ce lls p la ted on the a m p ic illin  p late, a s ing le  co lo n y  o f  bacteria  
was selected and placed in to  a un iversa l con ta in ing  5 m l o f  L B  con ta in in g  a m p ic illin  
(35 | ig /m l) . Th is  was g row n ove rn igh t at 37°C, and agitated at 150 rpm . 
A p p ro x im a te ly  16 h r later, 1.5 m l o f  the cu ltu re  was transferred to  a s te rile  m ic ro fuge  
tube. T h is  was m ic ro fuged  fo r  1 m in  and the resu ltant supernatant aspirated. The 
pe lle t was resuspended in  100 |Lil o f  so lu tion  1, (50 m M  glucose, 25 m M  T r is -H C l pH
8.0, 10 m M  E thylened iam inete tra-acetic  acid (E D T A ) p H  8.0), vo rtexed  and le ft  at 
room  tem perature (R T ) fo r  5 m in  200(xl o f  so lu tion  2, (1%  S od ium  dodecy l sulphate 
(SDS) 0.2 M  N aO H ), was added to  the m ix tu re , w h ich  was inve rted  a num ber o f  
tim es and then placed on ice  fo r  5 m in . 150 ( i l  o f  ice -co ld  so lu tion  3, (3 M  Potassium  
Acetate (K A c ), 5 M  A ce tic  acid p H  4.8), was added to  the lysate w h ic h  was then 
placed on ice fo r  10 m in . T h is  was then m ic ro fuged  fo r  5 m in  at 10,000 rpm . The 
supernatant was rem oved and the heavy w h ite  p ro te in  p rec ip ita te  discarded. 150 ( i l  o f  
2 M  T riz m a  base, ch lo ro fo rm , and pheno l (pH  7.8) were added to  the supernatant. 
Th is was vo rtexed and m ic ro fuged  fo r  2 m in . The upper aqueous laye r was rem oved, 
avo id ing  the in terface, as th is  contains pro te in . 1  m l o f  1 0 0 % ethano l was added to 
th is  aqueous phase and incubated at -80°C  fo r  5 m in . A f te r  th is  incuba tion , the 
m in ip repa ra tion  was m ic ro fuged  fo r  10 m in . The supernatant was rem oved. A t  th is  
p o in t, a w h ite  pe lle t was observed. 2 5 0 |il o f  0 .3 M  S od ium  acetate (N a A c) was 
com bined w ith  the pe lle t and m ixed . 500 | i l  o f  100% ethano l was added and the 
m ix tu re  was le f t  at R T  fo r  10 m in , and then m ic ro fuged  at 10,000 rp m  fo r  10 m in . 
The supernatant was rem oved and the pe lle t was washed w ith  70%  ethano l and dried  
at 37°C. The pe lle t was resuspended in  25 |ul T r is -E D T A -T E , (10 m M  T r is -H C l pH
8.0, 1 m M  E D T A ), and stored at 4°C  p r io r  to d igestion .
2.3.4. Restriction digest and electrophoresis of miniprep plasmid DNA
The D N A  tha t was obta ined fro m  the m in ip repa ra tion  was digested as fo llo w s . 5 f i l  o f  
D N A  was added to the d igest m ix tu re  w h ich  conta ined 1 ( i l  o f  re s tr ic tio n  enzym e, 2.5 
Jill o f  10X  b u ffe r, (supp lied  w ith  com m erc ia l enzym e), and 16.5 [ i l o f  s te rile  w ater and
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RNase, (2 | i l  o f  RNase A  in  T E , 50 flg /m l, and 14.5 | l l  o f  w ater). T h is  was incubated 
at 37°C  fo r  at least 2 hr. 12.5 p i o f  the d igest was rem oved,and 2.5 ( i l  o f  ge l load ing  
bu ffe r, 6 X  sucrose, b rom opheno l b lue, xy lene cyano l (S B X ), (40%  w /v  sucrose, 
0 .25%  w /v  b rom opheno l b lue, 0.2%  xylene  cyano l), was added. 15 f i l  was loaded 
onto a 1.2 % agarose gel. The gel was run  at 100 V  and 200 m A  in  0 .5 X  T ris -b o ric - 
acid E D T A  (T B E ) b u ffe r, (108g T ris  base, 55g o f  B o r ic  acid, 9 .3g E D T A -1 L  10X  
stock, p H  8.2-8.4). F o llo w in g  electrophoresis, the gel was stained in  e th id iu m  
brom ide , (0.5 (tg /m l), and v iew ed  using  the U V  trans illum ina to r.
2 .3 .5 . M a x ip rep a ra tio n  o f  p la sm id  D N A
Once i t  had been established that the m in ip repara tion  cultures w ere  transform ed w ith  
the correct p lasm id  D N A  these cultures were used to inocu la te  800 m l o f  L B  w ith  
a m p ic ill in  (35 ( ig /m l). The procedure used was a m o d ific a tio n  o f  the a lka line  lys is  
technique (Zervos et al., 1988) w h ich  was perfo rm ed w ith  reagents made in  the 
labora to ry , and also using the PZ523 spin colum ns.
The bacteria  were pe lle ted fro m  the cu ltu re  at 10,000 rpm  fo r  5 m in  at 2-4°C. A n  
a liq u o t o f  th is  cu ltu re  was used to  prepare g lyce ro l stocks. 500 ( i l  o f  the cu ltu re  was 
m ixed  w ith  500 ( i l  o f  sterile  50%  g lyce ro l. These g lyce ro l stocks w ere then stored at 
-80°C  u n t il they were requ ired  fo r  setting up m in ip rep . cu ltures. The bacteria l p e lle t 
was resuspended in  a to ta l o f  24 m l o f  S o lu tion  A , (25 m M  T r is -C l, 10 m M  E D T A , 
p H  8.0). I t  was im po rtan t tha t the pe lle t was fu l ly  resuspended. 24 m l o f  room  
tem perature S o lu tion  B , (0.2 M  N aO H , 1.0% SDS), was added to  the suspension. 
T h is  was tho rough ly  m ixed  by  repeated gentle inve rs ion . The  lys is  was a llow ed  to  
occur u n t il the lysate became essentia lly u n ifo rm  and translucent. 24m l o f  ice -co ld  
S o lu tio n  C, (7.5 M  A m m o n iu m  Acetate), was added to the lysate. A  flo ccu le n t 
p rec ip ita te  appeared on tho rough m ix in g . The p ro te in  and c e llu la r debris was pe lle ted  
fro m  the m ix tu re  by  cen trifuga tio n  at 10,000 rpm  fo r  30 m in  at 2-4°C . 43 m l o f  100% 
isopropano l was added to  the resu ltan t supernatant. The D N A  was pe lle ted  fro m  the 
m ix tu re  by  cen trifuga tion  at 10,000 rp m  fo r  30 m in  at 20°C. The pe lle t was washed 
sequentia lly  in  70%  and 95%  ethanol, and the pe lle t was d ried  at 37°C  fo r  10-15 m in .
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The pe lle t was d isso lved in  1.5 m l o f  T E  con ta in ing  15 | i l  RNase (50  ( ig /m l). The 
sam ple was conso lida ted by  cen trifuga tion  fo r  1-2 m in  at 10,000 rpm . The sample 
was incubated at 37°C  in  a w ater bath fo r  15 m in . The sam ple was then extracted 
w ith  2 m l o f  pheno l (p H  7 .8 )-C h lo ro fo rm -Iso a m y l A lc o h o l (P C I), m ixe d  and then 
cen trifuged  at 13,000 rpm  fo r  2 m in . Th is  step was repeated, fo llo w e d  b y  a 
C h lo ro fo rm -Iso a m y l extraction . The resultant aqueous phase was transferred to  a 
fresh tube and 360 ( l l o f  5 M  N a C l was added to  the sample. The sam ple vo lu m e  was 
adjusted to  1.8 m l w ith  T E , p H  8.
The 1.8 m l sample was added in to  the reservo ir p o rtio n  o f  the PZ523 spin co lum n  and 
cen trifuged  at 1,100 rp m  fo r  12 m in . The p lasm id  was p rec ip ita ted  by adding 0.6 m l 
o f  isopropano l and 0.6 m l o f  100% ethanol and incuba ting  at -80°C  fo r  2 hr. T h is  was 
then cen trifuged fo r  20 m in  at 20°C. The pe lle t was washed w ith  4 m l o f  70%  ethanol 
and 4 m l o f  95%  ethanol 4 tim es. The pe lle t was d ried  at 37°C  fo r  10 m in  and 
d isso lved  in  TE.
2 .3 .6 . R estr ic tio n  d ig est, e lec tro p h o resis , an d  q u a n tita t io n  o f  m a x ip rep . p la sm id  
D N A
The D N A  obtained fro m  the m ax ip repara tion  was digested as described fo r  m in ip re p  
D N A , except that on ly  l p l  o f  D N A  was digested, and RNase was not inc luded  in  the 
reaction  m ix tu re . E lectrophoresis was also carried  ou t as described p rev ious ly . The 
D N A  concentration was determ ined by  m easuring the O .D . at 260 nm. A  1/100 
d ilu t io n  o f  the D N A  was made and the O .D . o f  th is  d ilu t io n  was read. The reading 
obta ined was m u lt ip lie d  by  100, to  take in to  considera tion  the d ilu tio n , and then 
m u lt ip lie d  b y  50, as 1 absorbance u n it s ign ifies  a D N A  concentra tion  o f  50 ( ig /in l. 
The p u r ity  o f  the preparation  was determ ined by  m easuring the O .D . at 280 nm  and 
ca lcu la ting  the ra tio  o f  O .D .26o/O .D .28o- A  clean prepara tion  o f  D N A  has a ra tio  o f  
1.8. L o w e r ra tios ind ica te  the presence o f  excess p ro te in  and h ighe r ra tios ind ica te  
tha t chrom osom al D N A  cou ld  be present.
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2.4. Tissue Culture Methods
2 .4 .1 . A d h ere n t ce ll cu ltu res
SW 620, SW 480, W iD r  and A 5 4 9  were cu ltu red  in  D u lb e cco ’ s m o d ific a tio n  o f  
E ag le ’ s m ed ium  (D M E M ) con ta in ing  5%  foe ta l c a lf  serum  (FC S) (v /v ), L -g lu ta m in e  
(2  m M ), Hepes (1 m M ), p e n ic ill in  (1 u n it/m l), and s trep tom yc in  (1 |ig /m l) . A l l  
cu ltures were seeded in to  25 cm 3 and 75 cm 3 cu ltu re  flasks. F o r passaging adherent 
ce ll lines i t  is necessary to  tryps in ise  the cells. F irs tly  the cu ltu re  m e d iu m  is  decanted. 
The cu ltu re  vessel is then flushed out w ith  phosphate bu ffe red  saline (PBS). T h is  has 
a tw o fo ld  e ffec t in  that i t  ensures a ll FCS, w h ich  cou ld  p o te n tia lly  in te rfe re  w ith  
tryp s in  ac tiv ity , is rem oved and secondly, any non-adherent dead ce lls  are rem oved. 
A  2.5 m l a liquo t o f  the try p s in -E D T A  so lu tion , (tryps in  0 .25% , w ith  0 .02%  E D T A  in  
sterile  PBS), was added to  the flasks. The cu ltu re  was incubated at 37°C  fo r  10 m in . 
The c e ll suspension was added to  a un iversa l con ta ine r con ta in ing  5 m l o f  com ple te  
cu ltu re  m ed ium , 1 0 0  |ul was rem oved fo r  a ce ll count, and the rem a in ing  ce ll 
suspension was cen trifuged at 2000 rp m  fo r  5 m in . C e lls  were resuspended in  the 
appropria te  am ount o f  cu ltu re  m ed ium  and seeded in to  cu ltu re  flasks o r plates. A l l  
c e ll lines were incubated in  a hum id , 5%  C O 2 atmosphere at 37°C.
2 .4 .2 . C e ll C ou n ts
C e ll counts w ere perfo rm ed on a N eubauer H aem ocytom eter s lide  using  the T rypan  
b lue stain. 2 0  | i l  o f  trypan b lue  was added to the 1 0 0  fil c e ll sample taken a fter 
tryps in isa tion . Th is  was exam ined after 5 m in  by  l ig h t  m icroscopy. L iv e  ce lls  
exclude the stain and m a in ta in  th e ir in te g rity  w h ile  dead ce lls sta in b lue. The  num ber 
o f  ce lls  in  the f iv e  squares was counted. Th is  fig u re  was d iv id e d  by  5, m u lt ip lie d  by
1 .2 . to  take in to  considera tion  the d ilu tio n  o f  the cells, and then m u lt ip lie d  b y  1 x  1 0 4 
to  take in to  account the d im ensions o f  the haem ocytom eter. The resultant fig u re  is  the 
num ber o f  ce lls /m l, in  the c e ll sample the a liquo t fo r  coun ting  was taken.
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2.4.3. Storage of cell lines
Stocks o f  cells were m a in ta ined  in  the liq u id  phase o f  liq u id  n itrogen  in  C ryofreezer, 
(C ooper C ryoserv ice  L td .). W ashed cells were resuspended dropw ise  in  1m l o f  ice- 
co ld  FCS supplem ented w ith  5% (v /v ) (D M S O ) and transferred to  sterile  cryotubes. 
The cryotubes were low ered  s lo w ly  one leve l at a tim e  over 2 hr, in to  the gas phase 
and even tua lly  in to  the l iq u id  phase o f  liq u id  n itrogen.
C ells  w ere recovered fro m  liq u id  n itrogen  by th aw ing  them  ra p id ly  at 37°C  and then 
wash ing in  com plete m edium . The cells were cen trifuged  at 1000 rp m  fo r  5 m in  and 
resuspended in  com plete m ed ium .
2 .4 .4 . M y co p la sm a  d etectio n  - H o ech st 33258  flu o rescen t a ssa y
M ycop lasm a was detected using  the Hoechst stain. The m ethod used was tha t f irs t  
described by Chen, (1977) and m o d ifie d  by  C a rro ll et al., (1988). B isb e n z im id , 
(H oechst 33258) is a D N A  in te rche la to r w h ich  detects m ycop lasm a in  ce llu la r 
cytop lasm . 5 x  103 m ycoplasm a fre e -N R K  cells w ere cu ltu red  ove rn igh t in  1m l o f  
com plete m ed ium  on covers lips. C u ltu re  supernatant was rem oved fro m  the test ce ll 
line  and added to  the N R K  ce lls  w h ich  were incubated fo r  a fu rth e r 3-4 days. The 
covers lips were then washed 3 tim es in  PBS and f ix e d  fo r  6  m in  in  m ethanol:acetone 
(1 :1 ) so lu tion  at -20°C . The covers lips were then washed 3 tim es in  PBS and 
incubated fo r  10 m in  w ith  the Hoechst stain. The covers lips  w ere washed again to  
rem ove unused stain and m ounted on fresh slides. Samples were stored in  the dark  
u n t il v iew ed  under U V  lig h t on a N ik o n  fluorescence m icroscope at 100X  
m a gn ifica tion  w ith  o il im m ers ion  and a B 2  com b ina tion  filte r .
2.5  O p tim isa tio n  o f  tra n sfec tio n
In  order to op tim ise  trans fec tion  and com pare the e ffic ie n cy  o f  trans fec tion  o f  the 
d iffe re n t methods, the p lasm id  p C H llO  w h ich  codes fo r  (3-galactosidase was used in  
these transfection  op tim isa tio n  experim ents. The p roduct o f  th is  p lasm id  can be
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assayed e ither c o lo u rim e tr ic a lly  using a synthetic substrate (2 .6 .3 ) o f  b y  d irec t in situ 
sta in ing  o f  the ce lls (2.6 .4).
2 .5 .1 . D E A E -d ex tra n -M eth o d  A
The fo llo w in g  m ethod was adapted fro m  a paper by  M o r t lo c k  et al. (1993). 24 h r 
before  transfection , ce lls were trypsin ised  and seeded in to  1 0 0  m m  plates at a density 
o f  1 x  106, in  10 m l o f  m ed ium . A  stock so lu tion  o f  D E A E -d e x tra n , 10 m g /m l in  PBS 
was prepared and f i l te r  s terilised. V a rious  amounts o f  D N A  rang ing  fro m  1-10 | lg  
were placed in  a po lystyrene tube. The vo lum es w ere adjusted to  560 |ll1 w ith  sterile  
PBS, w ith o u t Ca++ and M g ++. F in a lly  12 | i l  o f  the D E A E -d e x tra n  s tock so lu tion , (10 
m g /m l) was added to  the transfection  m ix tu re . The f in a l vo lu m e  was 572 | i l  and the 
f in a l concentra tion  o f  D E A E -d e x tra n  was 200 fig /m l.
The m ed ium  was aspirated, and the plates were rinsed  in  PBS. The trans fec tion  
so lu tion , 572 f i l  was added to  the cells and the d ish  was t ilte d  to ensure even 
spreading o f  the transfection  so lu tion . The ce lls were then incubated at 37°C  fo r  1 hr. 
Several m in  before  the end o f  the 1 h r incuba tion , ch lo roqu in e  was added to  the 
requ ired  vo lum e o f  D M E M  to  a f in a l concentra tion  o f  100 } iM . The transfec tion  
so lu tion  was rem oved fro m  the ce lls and 6  m l o f  the ch lo roqu in e  m ed ium  was added. 
The dishes w ere transferred to  the 37°C incubator, and incubated  fo r  up to 4  hr. The 
ch lo roqu ine  m ed ium  was then rem oved and replaced w ith  10 m l o f  D M E M . The ce lls 
were returned to  the incuba to r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  
the transfected gene.
2 .5 .2 . D E A E -d ex tra n  M eth o d  B
T h is  m ethod was adapted fro m  a paper b y  Lopata  et al., (1984). 1 x  106 ce lls  were 
p la ted out on 100 m m  plates and a llow ed to  g row  fo r  24 hr. V a rious  amounts o f  the 
D N A  were placed in  a po lystyrene  tube and the vo lum es were adjusted to  4 0 | i l  w ith  
T r is  bu ffe red  saline (T B S ), (154 m M  N aC l, 50 m M  T ris  pH 7 .5  and 1 m M  M g C ^ ). 
Th is  was then added to  various volum es o f  w arm  (37°C ), 10 m g /m l D E A E -d e x tra n  in  
TB S . The concentrations o f  D E A E -dex tran  investiga ted ranged fro m  100-400 |lg /m l.
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The m ed ium  was aspirated fro m  the plates, w h ich  w ere then rinsed  w ith  PBS and 4 m l 
o f  fresh m ed ium  was then added to  the plates. The D N A /D E A E -d e x tra n  m ix tu re  was 
added dropw ise to  each plate, s w ir lin g  between each drop. The plates w ere incubated 
at 37°C  fo r  4 h r in  a tissue cu ltu re  incubator. The D N A /D E A E -d e x tra n  m ix tu re  was 
then aspirated fro m  the plates. The cells were then shocked by  adding 5 m l o f  10% 
D M S O  in  PBS fo r  1 m in  at RT. The D M S O  was aspirated and the ce lls  w ere then 
washed w ith  PBS. 10 m l o f  com plete m ed ium  was then added to  the cells. The ce lls  
were returned to the incuba to r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  
the transfected gene.
2 .5 .3 . B ea d  tra n sfectio n
24 h r before transfection  ce lls were tryps in ised  and seeded at a density o f  1 x  106 in  
100 m m  plates. G lass beads, 425 |lm  in  diam eter, w ere obta ined fro m  S igm a and 
treated accord ing to  the m ethod o f  M a c N e il and W arder, (1987), w ith  the fo llo w in g  
m od ifica tions . The beads were f irs t acid-washed in  2 vo lum es o f  5 M  HC1 fo r  12 h r 
and rinsed 5 tim es w ith  sterile  d is tille d  water. The beads were a lka li-w ashed  w ith  2 
vo lum es o f  4 M  N a O H  fo r  12 h r and rinsed in  d is tille d  w a te r u n t il the p H  o f  the wash 
w a te r was 7.0. The beads w ere soaked in  70%  isopropano l fo r  2 h r and rinsed w ith  a 
phys io log ic  b u ffe r (b u ffe r A : 140 m M  KC1, 10 m M  Hepes [p H  7 .25 ], Im M  E D T A , 
0.193 m M  C a lc iu m  ch lo ride  (C aC h), 10 m M  glucose, Im M  M g C l2 and 1 m M  
M agnesium  adenosine triphosphate (M g A T P )).
The ce lls w ere washed tw ice  w ith  PBS and fu rth e r washed w ith  b u ffe r  A  (w ith o u t 
M g A T P ). V a rious amounts o f  D N A , (25, 50 and 100 fxg/m l), w ere added to  2  m l o f  
b u ffe r A  (w ith  M g A T P ) together w ith  0.4 m l (approxim ate  vo lum e) o f  glass beads to 
the cells. The beads were d is tribu ted  over the ce lls  b y  t i l t in g  the p la te  at an angle o f  
45° in  a backw ard  and fo rw a rd  m o tion  up  to  4 tim es. The beads and the D N A -  
con ta in ing  so lu tion  w ere washed o f f  w ith  5 m l o f  b u ffe r  A  w ith  M g A T P  and then 10 
m l o f  appropria te m ed ia  was added and the plates w ere re turned to 37°C. The ce lls  
were returned to  the incuba to r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  
the transfected gene.
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2.5.4. Transfection with the lipopolyamine polybrene
Polybrene was prepared in  sterile  d is tille d  w ater at a concentra tion  o f  3 m g /m l and 
stored at -20°C  in  sm a ll a liquo ts (50 | l l) .  T ransfec tion  was pe rfo rm ed  accord ing to  the 
m ethod o f  D o lla rd  et al., (1993) w ith  m in o r m od ifica tions . B r ie f ly ,  various am ounts 
o f  D N A , (2.5, 5, 10 |ig ), were added to  10 m l o f  D M E M  m e d iu m  con ta in in g  
Polybrene, ( concentrations exam ined 30, 10, 5 |lg /m l) , and a llow ed  to  stand at R T  fo r  
15 m in . The com plexes w ere then added to  ce lls tha t had been seeded one day ea rlie r 
at 1 x  106 in  100 m m  plates. A fte r  a 3 h r incuba tio n  in  the 5%  C O 2 incuba to r, the 
trans fec tion  m ed ium  was rem oved and the ce lls re fed w ith  D M E M . The transfec tion  
m ix tu re  was rem oved a fte r 3 h r o f  contact and the ce lls  w ere  re fed  w ith  D M E M . The 
e ffec t o f  a g lyce ro l shock was also investigated. 3 m l o f  a 10% g lyce ro l so lu tio n  in  
Hepes bu ffe red  saline (H B S -280  m M  N aC l, 50 m M  Hepes, 1.5 m M  D is o d iu m  
hydrogen phosphate anhydrous (NaaHPCU)), was added to  the ce lls fo r  3 m in  at R .T . 
The g lyce ro l so lu tion  was rem oved and the ce lls  refed. The ce lls w ere re tu rned to  the 
incubato r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  the transfected gene.
2 .5 .5 . CaPC>4 m eth o d  o f  tra n sfectio n
T h is  m ethod was f irs t  described b y  G raham  and V a n  der E b  et al., (1973). 24 h r 
before  transfection  ce lls  w ere tryps in ised  and seeded at a density o f  1  x  1 0 6 in  1 0 0  m m  
plates. V a rious  amounts o f  D N A  were a liquo ted  in  sterile  po lystyrene tubes and the 
vo lum e  was adjusted to  410 | l l  w ith  sterile  H 2O. 480 p i o f  2 X  H B S  was a liquo ted  fo r  
each vo lum e  o f  D N A . 60 | l l  o f  2.5 M  C aC l2 was added dropw ise in to  the tube 
con ta in ing  the D N A  w ith  con tinua l m ix in g  us ing  a vo rte x  m ixe r. Im m e d ia te ly  the 
D N A -C a C l2 m ix tu re  was added dropw ise in to  the 2 X  H B S , w ith  continous m ix in g  
using  the vo rte x  m ixe r. T h is  was then le f t  in  the la m in a r f lo w  at R T  fo r  30 m in  
exactly. The ce lls  w ere rem oved fro m  the incuba to r, and the D N A -C a P 0 4  m ix tu re  
was added dropw ise to  the cells. The plate was sw ir le d  gen tly  to  ensure even m ix in g . 
The plates were re turned to  the incubato r fo r  va rious lengths o f  tim e , rang ing  fro m  4 
h r to  24 hr. T o  a id  the en try  o f  D N A  a g lyce ro l shock was carried  out. The  m ed ia  and 
the prec ip ita te  was rem oved fro m  the cells. 3 m l o f  10% g lyce ro l in  I X  H B S  was
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added fo r  3 m in . The g lyce ro l was rem oved, the ce lls  were rinsed in  PBS and serum - 
free m ed ium  and then re fed w ith  fresh g row th  m ed ium . The ce lls  w ere re tu rned  to  the 
incuba to r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  the transfected gene.
2 .5 .6 . T ra n sfec tio n  b y  e lec tro p o ra tio n
T h is  m ethod invo lves  the app lica tion  o f  b rie f, h igh -vo ltag e  e lec tric  pulses w h ic h  
results in  the fo rm a tio n  o f  nanom eter sized pores in  the p lasm a m em brane, (N eum ann 
et al. 1982; Z im m erm ann  et al., 1982).
Cells that were 50% -70%  con fluen t were used in  th is experim ent. One o r tw o  days 
before e lectropora tion , the ce lls were passaged to  ensure that the ce lls  w ere in  o p tim a l, 
log-phase g row th  cond itions  p r io r  to  harvesting fo r  the experim ent.
The m edia  was changed 4 h r before harvesting. The ce lls  w ere then tryps in ised  at 
4°C. The pe lle t was resuspended in  5 m l o f  m edia. A n  a liq u o t fo r  a c e ll coun t was 
taken. The ce lls  were pe lle ted  by ce n trifug ing  at 2 ,000 rp m  fo r  5 m in . These were 
le f t  on ice  u n t il the ce ll counts had been carried  out. 10 pg  o f  D N A  was added to the 
e lectropora tion  cuvette. The ce lls were resuspended at a f in a l concentra tion  o f  5 x  106 
to  1 x  107 ce lls /  800 p i o f  D M E M  at 0°C. The ce lls were added to  the e lec tropora tion  
cuvette. The D N A  and the ce lls were m ixed  and the cuvettes were le f t  on ice  fo r  5 
m in  o r longer. The resistance was set at °o. The capacitance was set at 25, 500, and 
960 pF. The vo ltage was va ried  fro m  0.2 to 1.7 k i lo  vo lts  (k V ). The cuvettes were 
then re turned to  ice  fo r  10 m in . The transfected ce lls  w ere d ilu te d  2 0 -fo ld  in  non- 
selective m edia, in  100 m m  plates. The cuvette was rinsed w ith  the same m ed ia  so as 
to  transfer a ll transfected cells. The ce lls were re turned to  the incuba to r fo r  48 h r and 
then harvested and assayed fo r  a c tiv ity  o f  the transfected gene.
2 .5 .7 . T ra n sfec tio n  u sin g  L ip o fecta m in e  rea g en t
Cells were seeded at 5 x  105 in  60 m m  dishes one day p r io r  to  transfection . V a rious  
amounts o f  D N A , (0.5, 1.0, 3.0, 5.0, and 10 pg ), were placed in  s te rile  tubes and the 
vo lum e was adjusted to 100 p i using serum -free m edia. F o r each q uan tity  o f  D N A  
2 0 p l o f  lipo fec tam ine  was placed in  a sterile  tube and 80 p i o f  serum -free m edia
41
added. These m ix tu res  w ere com bined and a llow ed  to  s it at R T  fo r  30 m in . Then, 
800 |ul o f  m edia was added to  the m ice lle  m ix tu re  and layered over a p late o f  ce lls  tha t 
had been rinsed three tim es in  serum -free m edia. The plates w ere incubated fo r  5 h r at 
37°C. The m ed ium  was then changed to serum -conta in ing  m edia. The ce lls  w ere 
re turned to  the incuba to r fo r  48 h r and then harvested and assayed fo r  a c tiv ity  o f  the 
transfected gene.
2 .5 .8 . T ra n sfec tio n  u s in g  D O T A P  rea g en t
C ells were seeded at 2.5 x  105 in  60 m m  dishes one day p r io r  to  transfection . 
Q uantities o f  D N A  were d ilu ted  to  a concentra tion  o f  0.1 | lg / | i l  in  20 m M  Hepes 
bu ffe r. In  a separate tube quantities o f  D O T A P  w ere m ixe d  w ith  20 m M  Hepes, so 
tha t the f in a l concentra tion  o f  D O T A P  was 0.3 | ig /p l.  The D N A  and D O T A P  were 
m ixed  and th is  transfection  m ix tu re  was incubated at R T  fo r  10-15 m in . 
Subsequently, the D O T A P /D N A  m ix tu re  was added d ire c tly  to  the 5-6 m l o f  cu ltu re  
m ed ium  and gently  m ixe d  by rock ing  the cu ltu re  d ish  to  ensure an equal d is tr ib u tio n  
o f  the transfection  m ix tu re . The ce lls were incubated w ith  the D O T A P /D N A  m ix tu re  
fo r  approx im ate ly  6  hr. The m ed ium  was replaced w ith  fresh cu ltu re  m ed ium . The 
ce lls w ere re turned to the incubato r fo r  48 h r and then harvested and assayed fo r  
a c tiv ity  o f  the transfected gene.
V a ria tions  were carried  out in  the am ount o f  D N A  and the ra tio  o f  D N A  to  D O T A P  
used. In it ia lly  the D N A  concentra tion  was kep t constant at 5 | lg  and the 
D N A :D O T A P  ra tio  was va ried  fro m  1:1 to  1:6. The o p tim u m  ra tio  was then p icke d  
to op tim ise  the concentra tion  o f  D N A  in  the range o f  2.5 to 20 [ig  o f  D N A .
2.6 . A ssa y in g  fo r  p -g a la cto sid a se  a ctiv ity
The p lasm id  p C H llO ,  w h ich  codes fo r  P-galactosidase, was used in  these 
op tim isa tion  experim ents. The assays used to repo rt transfection  e ffic ie n cy  detected 
leve ls o f  (3-galactosidase.
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2.6.1. Harvesting cells after transfection
The ce lls were rinsed tw ice  w ith  PBS, befo re  they w ere harvested. The ce lls  w ere 
harvested by  scraping in  1 m l o f  TB S , and cen trifuged  at 4°C  fo r  5 m in . The  p e lle t 
was resuspended in  60 p i o f  TB S . T h is  was freeze /  thaw ed fo u r tim es, ( 5 m in  at - 
80°C, fo llo w e d  b y  5 m in  at 37°C). The resu lting  lysate was m in ifu g e d  at top  speed fo r  
5 m in  at 4°C . The supernatant was rem oved and analyzed fo r  p ro te in  and (3- 
galactosidase content.
2 .6 .2 . B C A  p ro te in  m icro a ssa y
The b ich in ch o n in ic  acid (B C A ) p ro te in  assay reagent used was supp lied  by  Pierce, 
(table 2.1.2). The w o rk in g  reagent was made by com b in ing  50 parts reagent A  w ith  1 
pa rt reagent B . A  set o f  p ro te in  standards was prepared using  B S A  in  the range 0.1-
2 . 0  m g/m l. 1 0  p i o f  each standard, b la n k  o r u nknow n  sample was p ipe tted  in to  the 
appropria te m ic ro tite r p late w e lls . 2 0 0  p i o f  w o rk in g  reagent was added to  each w e ll. 
The samples w ere m ixe d  fo r  30 s on a m ic ro tite r  p late shaker. The m ic ro tite r  plate 
was covered and incubated at 37°C  fo r  30 m in . The absorbance was read at 560 nm , 
on a m ic ro titre  p late reader.
2 .6 .3 . A ssa y  o f  (3-galactosidase in  ce ll ex tra cts
0.1 m l o f  a 15 m g /  m l CPRG, s o lu t io n / ch lo rophe ny l red (3-d galactoside) prepared in  
b u ffe r A  (100 m M  sod ium  d ihydrogen phosphate (N a H 2P0 4) p H  7.2, 10 m M  KC1, 1 
m M  M g C l2 and 10 m M  (3-mercaptoethanol) w ith o u t (3-mercaptoethanol, was p laced in  
a 1.5 m l eppendorf fo r  each sample. E qua l quantities o f  p ro te in  w ere loaded fo r  each 
sample and the vo lum e  was adjusted to  510 p i w ith  b u ffe r A . Standards were 
prepared using  a com m erc ia l s tock o f  the enzym e (3-galactosidase, in  the 0 . 1  to  2.5 ng 
(0.2 to 5.0 ng /  m l) range. 0.1 m l o f  the 15 m g /  m l C PR G  so lu tion  was added to  each 
standard and the vo lum e  was adjusted to  510 p i w ith  b u ffe r A . These were incubated 
at 37°C  overn igh t. A  co lou r change fro m  orange to  red ind icates a p o s itive  result. 
The absorbance o f  these samples was read at 560 nm  on a m ic ro titre  p la te  reader.
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2.6.4. Assay of (3-galactosidase using an in-situ stain
The ce lls were washed tw ice  w ith  PBS. The ce lls were fix e d  w ith  10 m l, (10  m l fo r  
100 m m  plates, 5 m l fo r  60 m m  plates), o f  f ix  so lu tion , ( fo r  50 m l o f  f ix  so lu tio n - 0.4 
m l o f  25 % glutara ldehyde, 10 m l o f  0.1 M  phosphate b u ffe r p H  7.3, 2.5 m l o f  0.1 M  
E thylene g lyco l-b is  ((3-am inoethyl ether) N ,N ,N \N ’ -te tra-acetic acid (E G T A ) p H  8.0, 
0.1 m l o f  1.0 M  M g C l2 and 37 m l o f  d is tille d  w ater), fo r  10 m in  at R .T . T h is  step was 
repeated. The ce lls  were then washed tw ice  fo r  10 m in  w ith  10 m l o f  rinse  so lu tion , ( 
fo r  200 m l o f  rinse so lu tion - 40 m l o f  0.1 M  phosphate b u ffe r  pH 7 .3 , 160 m l o f  
d is tille d  w ater, 0.4 m l o f  1 M  M g C l2 , 20 m g o f  sod ium  deoxycho late and 40  | i l  o f  N P - 
40). The ce lls  were then stained w ith  2.5 m l, ( 2.5 m l fo r  100 m m  plates, 1.5 fo r  60 
m m  plates), o f  stain so lu tion , ( 10 m l o f  rinse so lu tion : 0.4 m l o f  X -g a l(5 -B ro m o -4 - 
ch lo ro -3  indoyl-|3  D -galactoside, 25 m g /m l so lu tion  in  d im e th y l fo rm am ide ), 16.5 m g 
o f  Potassium  fe rricyan ide  (K 3F e (C N )6) and 16.5 m g o f  Potassium  fe rrocyan ide  
(K 4F e (C N )6)).
The plates w ere incubated ove rn igh t at 37°C. The next day the ce lls  were observed 
under a m icroscope. P os itive  ce lls stain b lue  w h ile  the negative ce lls  rem ained clear. 
The num ber o f  b lue  ce lls in  the w ho le  p late w ere counted. The sta in was rem oved 
fro m  the plates, and 5 m l o f  rinse so lu tion  was added. The plate was covered w ith  
p a ra film  and stored in d e fin ite ly  at 4°C.
2 .7  In v estig a tin g  th e  tra n scr ip tio n a l reg u la tio n  o f  m a tr ily s in  g en e  ex p re sss io n
2 .7 .1 . S tim u la tin g  th e A 5 4 9  tra n sfected  ce lls  w ith  E G F  a n d  T P  A
The A 5 4 9  ce lls  w h ich  w ere transfected w ith  the m a tr ily s in  p rom o te r reporter 
constructs, were stim ula ted w ith  E G F  and T P A , to  establish the regu la to ry  e ffec t that 
they had on m a tr ily s in  gene expression. E G F  was used at a concentra tion  o f  5 ng /m l, 
and T P A  at 100 ng /m l. The appropria te vo lum es o f  these factors w ere added to  the 
A 5 4 9  transfected ce lls  a fter they had been incubated in  serum -free m edia  fo r  8 hr. 
C A T  p ro te in  analysis was carried  out 24 h r later.
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2 .7 .2 . A n a ly s is  o f  C A T  p ro te in  u s in g  a  C A T  en zy m e lin k ed  im m u n o so rb a n t  
assa y  (E L IS A )
C ells  w ere harvested fo r analysis b y  asp ira ting  the m ed ium  and w ash ing  the ce lls three 
tim es in  PBS. A  7 5 0 p l a liq u o t o f  T r is -E D T A -N a C l-T E N  (40  m M  T r is -H C l, 1 m M  
E D T A , 150 m M  N a C l, p H  7 .8) was added to  the cells. The ce lls  w ere  rem oved fro m  
the p late by  scraping and trans fe rring  in to  a m ic ro fuge  tube. The p la te  was rinsed 
w ith  400 p i o f  T E N  and added to  the m ic ro fuge  tube. The ce lls  were cen trifuged  fo r  1 
m in  and the supernatant was aspirated. The p e lle t was resuspended in  150 p i o f  T r is  
b u ffe r, p H  7.8. T h is  was freeze /  thaw ed as p rev ious ly  described in  2.6.1.
P ro te in  de te rm ina tion  o f  the ce ll extracts was perfo rm ed using  the b io ra d  p ro te in  
m icroassay procedure. Standards were made in  the 1-20 pg  /  m l range. E qua l 
amounts o f  p ro te in  were loaded fo r  each ce ll extract in  the C A T  E L IS A . C A T  
enzym e standards fo r  the E L IS A  were prepared in  the 20 - 200 pg  /  200 pg  range.
The C A T  antibod ies (a n ti-C A T ) coated to  the surface o f  the w e lls  o f  the com m erc ia l 
p late were rehydrated using sample b u ffe r (a ll bu ffe rs  and reagents w ere supp lied  in  
the k it) .  200 p i o f  each standard and sample was p ipe tted  in to  the w e lls . A l l  C A T  
conta ined in  c e ll extracts and standards b inds spec ifica lly  to  the a n ti-C A T  antibodies 
bound to  the surface o f  the w e lls . The plate was covered and incubated at 37°C  fo r  1 
hr. The samples and standards w ere d iscarded a fter 1 h r and the w e lls  w ere washed 4 
tim es w ith  w ash ing  b u ffe r and tapped on absorbent paper. 2 0 0  ( il o f  the d ig o x ig e n in - 
labeled an tibody to  C A T  (a n ti-C A T -D IG ) w o rk in g  d ilu t io n  was added to  each w e ll. 
The a n ti-C A T -D IG  antibody b inds to  the C A T  bound fro m  the samples and standards. 
The p late was covered and incubated at 37°C  fo r  1 hr. A f te r  the h r the so lu tion  was 
discarded and washed as described above. 2 0 0  p i o f  the an tibody to  d ig o x ig e n in  
conjugated to  peroxidase (an ti -D IG -P O D ) w o rk in g  d ilu tio n  was added to  the w e lls . 
T h is  an tibody b inds to  the d igox ige n in . The p la te  was covered and incubated  at 37°C 
fo r  1 hr. The  p la te  was then washed as described. Subsequently, 200  p i o f  the 
peroxidase substrate was added to  each w e ll. The peroxidase enzymes catalyses the 
cleavage o f  the substrate, p roduc ing  a co loured  reaction  product. The  p late was 
incubated at R .T . u n t il pos itive  samples showed a green co lou r. A n  incuba tio n  tim e  
o f  30 to  60 m in  was ro u tin e ly  used. The absorbance o f  the samples was m easured at
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405 nm , w ith  a reference w ave leng th  at approx im ate ly  490 nm  us ing  a m ic ro tite r  p late 
reader.
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Chapter 3
Results
&
Discussion
3.1 DNA preparation methods
A  num ber o f  p lasm ids w ere used in  the course o f  th is  w o rk . F o u r o f  these w ere 
m a tr ily s in  p rom ote r C A T  constructs, w h ich  were obta ined fro m  o u r co llabora to rs  in  
N a sh v ille , see figu re  2.1 fo r  details. These constructs are nam ed p -9 5 H P C A T , p- 
295 H P C A T , p -9 3 3 H P C A T  and p -4 .2H P C A T . A  negative and pos itive  co n tro l 
p lasm id  also had to  be prepared; p F L C A T  (obta ined fro m  N a sh v ille ) and p C M V C A T  
(obta ined fro m  D r. W a lls  D .C .U .). The p F L C A T  p lasm id  is  a negative co n tro l 
p lasm id  as i t  contains the S V 40  p rom o te r lin ke d  to the 3 ’ end o f  the C A T  gene, and 
therefore the C A T  gene is no t transcribed. The p C M V C A T  p lasm id  conta ins the 
C M Y  p rom ote r l in k ed to  the 5 ’ end o f  the C A T  gene, enab ling  the C A T  gene to  be 
transcribed. These plasm ids were used to  investigate the regu la tion  o f  m a tr ily s in  gene 
expression. The f in a l p lasm id  to  m en tion  was the p lasm id  p C H llO  that codes fo r  P- 
galactosidase. Th is  was used in  the transfection  op tim isa tio n  experim ents.
Sections 2.3.1 th rough to 2.3.6. ou tline  the procedures em p loyed  to prepare these 
p lasm ids. The  m axip repara tion  m ethod used is described in  de ta il in  section 2.3.5. 
and was an a lka line  lys is  m ethod based on w o rk  by  Zervos et al., (1987). The y ie ld  
and p u r ity  o f  p lasm id  D N A  was obta ined by m easuring the absorbance at 260 nm  and 
280 n m  as described in  section 2.3.6. A l l  the plasm ids were p u r if ie d  in  m g amounts. 
A l l  the O .D .260/O .D .280 ra tios were in  the acceptable range o f  1.8-2.0. T o  check that 
they w ere the correct p lasm ids, re s tric tio n  enzyme digests and electrophoresis o f  the 
d igestion  products were carried  out. Table 3.1.1. ou tlines the re s tr ic tio n  enzymes used 
to  cu t each p lasm id  and the expected fragm ent sizes obta ined as a resu lt o f  cu tting  
w ith  these enzymes, ca lcu la ted fro m  res tric tion  enzym e sites in  each p lasm id  map. 
F igu re  3.1.1. illus tra tes  the d igestion  products fo r  each p lasm id  e lectrophore ised on a
1.2 % gel and stained w ith  e th id iu m  brom ide.
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P la sm id R estr ic tio n  E n zy m es D ia g n o stic  C u t  
(b p )
p C H llO Pvu II 360, 700, 2,600, 
3 ,500
P -95H P C A T P vuII 425, 1,728, 2,567
P -295H P C A T Pvu II 535, 1,728, 2,567
P -933H P C A T Pvu II 1,278, 1,728, 
2,567
P -4 .2H P C A T Xho I, Bam H I 3,000,
6 ,0 0 0
p -F L C A T Ecor I, Bam HI 751, 1,382, 2 ,400
p C M V C A T P vu II 333, 1,727, 2,054, 
2,567
T a b le  3 .1 .1 . R estr ic tio n  a n a ly s is  o f  p la sm id s. T h is  table lis ts  the p lasm ids used 
du ring  the course o f  th is  w o rk , the res tric tion  enzymes used to  cu t them , and the 
resu ltan t fragm ents.
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Lanes 1 2 3 4 5 6 7 8
L an es
12,000 ----
3.000 —
2.000 —  
1,600 
1,000 __
500 ___
400
M a rk ers 1 k b p  lad d er
1 1  kbp markers
2 P -95H P C A T
3 P-295H P C A T
4 P -933H P C A T
5 P -4 .2H P C A T
6 p F L C A T
7 p C M Y C A T
8 p C H llO
F ig u re  3 .1 .1 . R estr ic tio n  an a ly sis  o f  p la sm id s. T h is  d iagram  illus tra tes the 
re s tr ic tio n  digest pattern fo r  each o f  the plasm ids.
3.1.2. Discussion
F igure  3.1.1., shows the products o f  the res tric tion  d igest o f  each o f  the p lasm ids 
fo llo w in g  electrophoresis on a 1.2 % gel. Lane 2 shows the d iagnostic  cu t fo r  the 
p lasm id  p -95H P C A T . F ro m  table 3.1.1., i t  can be seen that the correct bands obta ined 
a fter cu ttin g  th is  p lasm id  w ith  Pvu II, are 425, 1,728 and 2,567. C om paring  the bands 
in  lane 2 to  the m arker bands i t  can be seen that these bands are present. The  p lasm ids 
p -2 9 5 H P C A T  and p -9 3 3 H P C A T  in  lanes 3 and 4 respective ly , also con ta in  the 1,728 
and 2,567 bp bands. The characteristic 535 bp band obta ined w hen p -2 9 5 H P C A T  is 
cu t w ith  Pvu II  can also be seen in  lane 3 and co rrespond ing ly  the 1,278 bp  band o f  
the d iagnostic  Pvu II  cu t fo r  p -9 3 3 H P C A T  can be seen in  lane 4.
Lane 5 shows the 3,000 bp and 6,000 bp bands obta ined w hen the p la sm id  p- 
4 .2 H P C A T  is cu t w ith  Xho I  and Bam HI. The 6,000 bp m arker on th is  gel is  no t 
reso lved fro m  the o ther h ighe r bp markers as th is is  a 1 . 2  % gel and so com parison  o f  
the 6,000 bp band in  lane 5 and the correspond ing 6 ,000 bp band in  the m arker lane is 
d if f ic u lt .  A  lo w e r percentage gel (0 .6% ) w o u ld  reso lve these h ighe r bp  bands b u t the 
lo w e r bp markers w o u ld  then have to  be run  o f f  the gel w h ic h  are needed fo r  
com parison o f  the bands in  a ll the other d iagnostic  cuts. F o r the purposes o f  th is  
experim ent w h ich  was to  show a ll the d iagnostic cuts o f  a ll the p lasm ids on the one 
gel the 1 . 2  % ge l was used.
Lane 6  shows the bands 751, 1,382, and 2,400 bp, w h ic h  are obta ined w hen p F L C A T  
is cu t w ith  Ecor I  and Bam HI. Lane 7 and 8 illu s tra te  the co rrec t d iagnostic  Pvu II 
cuts fo r  the p C M V C A T  ( 333, 1,727, 2,054 and 2,567 bp) and p C H llO  ( 360, 700, 
2,600, and 3,500 bp), p lasm ids. A n y  h igher bp  bands in  any o f  the lanes, represent the 
linearised  and n icked  p lasm id .
The p lasm id  D N A  preparations were now  com pleted. E xperim en ts  o p tim is in g  the 
transfection  cond itions  in  the S W 620 or W iD r  ce ll lines cou ld  now  be carried  out. 
These ce ll lines were chosen because they endogenously express m a tr ily s in  and also 
m a tr ily s in  m R N A  expression has been shown to  be enhanced by  E G F  and T P A  (G aire  
et al., 1994). Once transfection  cond itions were op tim ised , experim ents inves tiga tin g  
the transcrip tiona l regu la tion  o f  m a tr ily s in  gene expression cou ld  then be carried  ou t
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b y  transfecting  the m a tr ily s in  p rom ote r constructs in to  e ithe r o f  these c e ll lines. The 
p lasm id  p C H llO  was used in  these transfection  o p tim isa tio n  experim ents. T h is  
p lasm id  codes fo r  the bacte ria l p ro te in  P-galactosidase w h ic h  can be assayed fo r  us ing  
the ch lo rophenyl red P-d galactoside (CPRG) assay (section 2.6.3.) o r the in-situ sta in 
(section 2.6.4.). F igure  3.1.2.1. illus tra tes a standard curve  fo r  the CPRG assay. T h is  
curve intercepts the y  axis at 0 . 1 1  (corresponding to  0  ng o f  P-galactosidase) thus a ll 
absorbance readings in  the op tim isa tio n  experim ents < 0 . 1 1  correspond to  negative  P* 
galactosidase values. Absorbance readings >  0.3 (corresponding to  0.15 ng o f  P- 
galactosidase) are s ig n ifica n t readings as they denote tha t the ce lls  w ere transfected 
s u ffic ie n tly  w ith  p C H l 10, fo r  transient transfection  assays (W ils o n  et al., 1995).
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50.0  0.5  1 . 0  1 . 5  2 . 0  2 . 5
Bota-gal (ng)
F ig u re  3 .I .2 .I .  P -g a la cto sid a se  s ta n d a rd  cu rv e
As can be seen th is  standard curve is linea r in  the 0-2.5 ng range o f  P-galactosidase 
ac tiv ity . T h is  curve intercepts the y  axis at 0.11 (correspond ing to 0 ng o f  P- 
gaiactosidase) thus a ll absorbance readings in  the op tim isa tion  experim ents <  0 . 1 1  
correspond to negative p-galactosidase values. Absorbance readings >  0.3 
(corresponding to 0.15 ng o f  P-galactosidase) are s ig n ifica n t readings as they denote 
that the ce lls  were transfected su ffic ie n tly  w ith  p C H llO ,  fo r  transient transfection  
assays (W ilso n  et a i, 1995).
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3.2. Optimisation of the DEAE-dextran methods A and B
The theore tica l basis o f  transfecting w ith  D E A E -d e x tra n  was discussed in  de ta il in  
section 1.4.1. D E A E -d e x tra n  is a p o lyca tion ic  m o lecu le  w h ic h  b inds the nega tive ly  
charged D N A . T h is  D N A -D E A E -d e x tra n  m ix tu re  w h ic h  is used to  transfect the ce lls  
is a solub le  m ix tu re  w ith  no v is ib le  precip ita te . T h is  m ix tu re  enters the ce lls  by 
endocytosis. The m a in  features to optim ise  w hen  using  th is  m ethod in c lude  the 
fo llo w in g . The f irs t  param eter is the p lated num ber o f  cells. I t  is  im po rtan t tha t 24 hr 
a fte r seeding the ce lls  are 30-50%  con fluen t as th is  is the ce ll density at w h ic h  
e ff ic ie n t transfection  can occur (Reeves et al., 1985). Secondly the concentra tion  o f  
D N A  and the D E A E -d e x tra n  used needs to  be optim ised . F in a lly  the leng th  o f  the 
incuba tion  tim e  o f  the transfection  m ix tu re  w ith  the ce lls , the use o f  a g lyce ro l shock 
and the use o f  ch lo roqu ine  also need to be considered.
T w o  varia tions o f  th is  m ethod were investigated. The f irs t  m ethod investiga ted  is 
re ferred to  as m ethod A . F o r experim enta l deta ils see section 2.5.1. O p tim isa tio n  
experim ents o f  the D E A E -d e x tra n  m ethod were carried  ou t in  the S W 620 ce ll line . 
T o  achieve a ce ll density o f  30-50%  24 h r a fte r seeding, i t  was necessary to  seed the 
plates w ith  1 x  106 ce lls in  10 m l o f  D M E M  con ta in ing  5%  FCS. A  range o f  D N A  
concentrations fro m  1-10 fig  per p late in  a f in a l vo lum e o f  572 f i l  were added to  each 
plate. D E A E -d e x tra n  was also inc luded  in  th is  vo lum e  at a concentra tion  o f  200 
(j-g/ml. T h is  was incubated w ith  the ce lls fo r  1 h r a fte r w h ich  tim e  i t  was rem oved  and 
6 m l o f  m ed ium  con ta in ing  ch lo roqu ine  (100 |0,M ) was added to  each plate. T h is  was 
le f t  on fo r  4  h r a fte r w h ich  tim e  i t  was replaced w ith  D M E M  p lus 5%  FCS. D up lica te  
plates w ere also set up  in  w h ich  no ch lo roqu ine  was added. 48 h r la te r the ce lls  were 
harvested and assayed fo r  pro te in , (sections 2 .6 . 1 . and 2 .6 .2 . fo r  deta ils), before 
proceeding w ith  the C PR G  assay. The results o f  th is  experim ent are o u tlin e d  in  table
3.2.1.
M e th o d  B  d iffe rs  fro m  m ethod A  in  tha t f irs t ly , no ch lo roqu ine  was used. Secondly 
the D N A -D E A E -d e x tra n  m ix tu re  was incubated fo r  a to ta l o f  4  h r in  a vo lum e  o f  4 m l 
and a shock using 10% D M S O  fo r  1 m in  was investigated. The results o f  th is 
experim ent are o u tlin e d  in  table 3.2.2.
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Sample DNA concentration
(Hg)
Chloroquine CPRG Assay 
Abs. At 560 nm
1 0 + 0 . 0 1 2
2 1 + 0.004
3 2 + 0 .0 0 2
4 4 + 0.000
5 6 + 0.003
6 8 + 0.005
7 1 0 + 0.005
8 1 - 0.006
9 2 - 0.003
1 0 4 - 0 .0 0 2
1 1 6 - 0.000
1 2 8 - 0 .006
13 1 0 - 0.004
14 w ater b lank 0.000
15 Positive ► 2.345
C o n tro l
Table 3.2.1. Optimisation of DEAE-dextran transfection method A in SW620 
cells. This table outlines the results obta ined fro m  o p tim isa tio n  experim ents 
in v o lv in g  m ethod A  on the S W 620 cells. Sam ple 1, the negative co n tro l fo r  the 
transfection  procedure, was a sample o f  S W 620 ce lls  w h ich  w ere no t transfected. 
Sample 14, the w ater b lank  was a negative co n tro l fo r  the C PR G  assay. Sam ple 15, 
the pos itive  co n tro l in vo lve d  incubating  1.25 ng o f  a com m erc ia l p repara tion  o f  the 
enzyme (i-galactosidase in  the reaction m ix tu re . S ig n ifica n t absorbance readings 
(>0.3) are designated b y  an arrow.
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Sample DNA (ng) 
conc.
DEAE-dextran
(pg/ml)
CPRG Assay 
Abs. at 560nm
1 1 400 -0.041
2 1 2 0 0 -0.047
3 1 1 0 0 -0 .034
4 4 400 -0.015
5 4 2 0 0 -0 .032
6 4 1 0 0 -0 .030
7 1 0 400 -0.029
8 1 0 2 0 0 -0.027
9 1 0 1 0 0 -0.027
1 0 0 2 0 0 -0.029
1 1 w ater b lank - 0 .0 0 0
1 2 Positive
C on tro l
-►  2.541
Table 3.2.2. Effect of DEAE-dextran concentration on SW620 cells. T h is  tab le  
outlines the results obta ined w hen m ethod B  was used fo r  the D E A E -d e x tra n  
op tim isa tion  on the S W 620 cells. These results w ere obta ined when a D M S O  shock 
was used. The experim ent was repeated w ith o u t the use o f  a D M S O  shock and the 
same results w ere obtained. Sam ple 10, the negative con tro l fo r  the trans fec tion  
procedure, was a sample o f  SW 620 ce lls w h ich  were transfected w ith  0 | ig  o f  D N A . 
Sample 11, the w ater b lank  was a negative co n tro l fo r  the C PR G  assay. Sam ple 12, 
the pos itive  co n tro l in vo lve d  incuba ting  1.25 ng o f  a com m erc ia l p repara tion  o f  the 
enzym e [i-galactosidase in  the reaction  m ix tu re . S ig n ifica n t absorbance readings 
(>0.3) are designated b y  an arrow .
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3.2.1. Discussion
A s can be seen fro m  table 3.2.1. samples 1-14 resulted in  absorbance readings that 
corresponded to  negative [3-galactosidase values, as a ll readings w ere < 0 . 1 1  (the [3- 
galactosidase standard curve intercepts the y  axis at 0 . 1 1 , co rrespond ing to  0  ng o f  (3- 
galactosidase). In  th is  experim ent tw o  cond itions w ere varied, the use o f  ch lo roqu in e  
and the am ount o f  D N A . The am ount o f  D E A E -d e x tra n  used was kep t constant at 
200 |lg /m l. A cco rd in g  to the lite ra tu re  the D E A E -d e x tra n  m ethod is su itab le  fo r  sm a ll 
amounts o f  D N A . The ranges o f  D N A  concentra tion  investiga ted, 1-10 |lg , 
adequately covered th is  c rite ria , so w e d id  no t deem th is  to be the p ro b le m  area.
The use o f  ch lo roqu ine  in  the incuba tion  m edia was investiga ted as i t  has been shown 
to  reduce degradation o f  endocytosed p lasm id  D N A , (M o rtlo c k  et al., 1993). In  th is 
experim ent ch lo roqu ine  was show n to have no e ffect. A s ch lo roqu in e  is  m eant to 
im p rove  transfection  e ffic ie n cy  i t  was surm ised tha t its la ck  o f  e ffec t in  th is  
experim ent po in ted  to  a la ck  o f  transfection , due to  the concentra tion  o f  D E A E - 
dextran used. A s  m entioned above the concentra tion  o f  D E A E -d e x tra n  was kep t 
constant at 200 p g /m l. B e fo re  d raw ing  the conc lus ion  tha t the D E A E -d e x tra n  m ethod 
was no t suitable fo r  the SW 620 ce lls w e decided to  exam ine a range o f  D E A E -d e x tra n  
concentrations and that lead us to  m ethod B .
In  th is  experim ent w e exam ined a series o f  D E A E -d e x tra n  concentra tions us ing  the 
same range o f  D N A  concentrations (1-10 |lg ) as fo r  m ethod A . T o  im p ro ve  uptake o f  
the D N A  by the cells, a D M S O  shock after the incuba tion  o f  the trans fec tion  m ix tu re  
w ith  the ce lls , was em ployed. The incuba tion  tim e  o f  the trans fec tion  m ix tu re  w ith  
the ce lls was increased fro m  1 h r to 4 hr. The e ffec t o f  ch lo roqu ine  in  th is  experim en t 
was no t investigated.
The results o f  th is  experim ent are ou tlined  in  table 3.2.2. A s  can be seen fro m  the 
results no va ria tio n  resulted in  transfected cells. I t  was concluded tha t ne ithe r D E A E - 
dextran m ethod was suitable fo r  transfection  o f  the S W 620 ce lls , as no va ria tio n  
em ployed w ith  e ithe r m ethod resulted in  transfected cells.
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3.3. Optimisation of Bead transfection
T h is  technique in vo lve s  rem ov ing  the cu ltu re  m ed ium  that the ce lls  have been 
g ro w in g  in , and rep lac ing  i t  w ith  a sm a ll vo lum e  o f  the D N A  to  be transfected. G lass 
beads are sp rink led  onto  the cells, agitated and the ce lls are washed free  o f  beads and 
exogenous m acrom olecu les and “ bead-load ing”  is com pleted.
The beads are though t to  cause a m om entary “ stress”  to  the c e ll m em brane a llo w in g  
perfo ra tions to fo rm  th rough w h ich  the D N A  can enter. The precise m ethod can be 
found  in  section 2.5.3. and background in fo rm a tio n  in  section 1.4.2.
The m a in  va riab le  in  th is  m ethod is D N A  concentration. P revious w o rk  carried  ou t by 
M athew s et al., (1993), recom m ended us ing  the 0.4 m m  beads as any sm a lle r size 
beads s tick  to  the cells, and any larger, cause perm anent ce ll damage. Three 
concentrations o f  D N A , (25 p g /m l, 50 p g /m l and 100 ( ig /m l), in  a 2 m l vo lum e , w ith  
the S W 620 ce lls  w ere exam ined. M athew s et al., (1993), recom m ended us ing  these 
concentrations in  op tim isa tion  experim ents. The results o f  th is  experim en t can be 
seen in  table 3.3.1.
3.3.1. Discussion
A s can be seen fro m  table 3.3.1., none o f  the S W 620 ce lls w ere transfected us ing  the 
glass bead m ethod. T h is  set o f  transfections was carried  ou t in  tw o  lo ts . A f te r  the 
in it ia l set o f  plates (samples 1-3) had been incubated 48 h r post-transfection , i t  was 
no ticed  tha t up  to  70 % o f  the ce lls had floa ted  o f f  a fter the transfection  procedure. 
The bead trans fec tion  was repeated bu t th is  tim e  the S W 620 ce lls  w ere seeded in  
plates tha t had been coated in  p o ly -L -lys in e . P o ly -L -lys in e  is a substance tha t is used 
to  fa c ilita te  stronger b in d in g  o f  the ce lls to  the tissue cu ltu re  plates.
O u r a im  was to  see i f  us ing  the p o ly -L - ly s in e  w o u ld  prevent so m any o f  the ce lls  fro m  
detaching a fte r the glass bead treatm ent. A fte r  the 48 h r post-transfection  incuba tio n  
the ce lls w ere observed and i t  was noted tha t the p o ly -L - ly s in e  had m a rg in a lly  reduced 
the detachm ent o f  the cells. A lth o u g h  th is  treatm ent im p ro ve d  ce ll adherence, (judged 
by  observing the ce lls  under m a gn ifica tion ), the results fro m  the C P R G  assay show  
that none o f  the S W 620 ce lls had been transfected, as samples 1-6 resu lted  in
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absorbance readings that corresponded to  negative (3-galactosidase values, as a ll 
readings were < 0 . 1 1  (the [5-galactosidase standard curve in tercepts the y  axis at 0 . 1 1 , 
correspond ing to  0  ng o f  (3-galactosidase)..
I t  was concluded that th is  m ethod was no t suitable fo r  the transfec tion  o f  the S W 620 
ce lls, p r im a rily  because the glass bead treatm ent caused excessive ce ll death and any 
o f  the rem a in ing  ce lls d id  no t take up s ig n ifica n t amounts o f  the p C H IIO  p lasm id .
Sample DNA (|i.g/ml) Poly-L- CPRG Assay
conc. lysine Abs. at 560 nm
1 25 . -0.064
2 50 - -0.068
3 1 0 0 - -0.093
4 25 + -0.056
5 50 + -0.061
6 1 0 0 + -0.059
7 - - 0 .0 0 0
8 w ater b la n k - 0 .0 0 0
9 Positive - -►  2.612
C o n tro l
Table 3.3.1. Optimisation of bead transfection on the SW620 cells. T h is  table 
shows the e ffec t o f  va ry ing  D N A  concentra tion  and also the e ffec t o f  us ing  p o ly -L - 
lys ine . Sam ple 7, the negative con tro l fo r  the transfection  procedure, was a sample o f  
S W 620 ce lls  w h ich  were no t transfected. Sample 8 , the w ater b la n k  was a negative 
con tro l fo r  the C P R G  assay. Sample 9, the pos itive  con tro l in v o lv e d  incuba ting  
1.25ng o f  a com m erc ia l prepara tion  o f  the enzym e (3-galactosidase in  the reaction  
m ix tu re . S ig n ifica n t absorbance readings (>0 .3 ) are designated b y  an arrow .
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The process o f  using ca tion ic  lip id s  to  transfect ce lls is k n o w n  as lip o fe c tio n . 
C a tion ic  vesicles in teract spontaneously and rap id ly  w ith  po lyan ions such as D N A , 
resu lting  in  liposom e/po lynuc leo tide  com plexes that capture p ra c tica lly  1 0 0  % o f  the 
po lynuc leo tide . The resu lting  p o lyca tion ic  com plexes are taken up b y  the an ion ic  
surfaces o f  tissue cu ltu re  cells. Po lybrene is a ca tion ic  l ip id  ava ilab le  fro m  A ld r ic h . 
C onsu lt section 1.4.5. fo r  in fo rm a tio n  on the process o f  lip o fe c tio n  and section  2.5.4. 
fo r  the precise m ethods in vo lve d  in  us ing  po lybrene to  transfect cells.
The c r it ic a l factors fo r  op tim isa tion  o f  the lip o fe c tio n  procedure are the am ount o f  
D N A  and l ip id  fo rm u la tio n  used.
Polybrene was used in  transfection  experim ents w ith  the S W 620 ce lls . Three 
concentrations o f  D N A , 2.5, 5, and 10 flg /m l, and three concentrations o f  po lybrene 
were investiga ted  according to  the m ethod o f  D o lla rd  et a i, (1993). The e ffec t o f  a 
g lyce ro l shock was also exam ined. The results o f  these experim ents can be seen in  
tables 3.4.1.-3.4 .3.
3.4. Transfection with the lipopolyamine Polybrene
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Sample DNA (,ig) 
conc.
Polybrene (|ig/ml) 
conc.
Glycerol
shock
CPRG 
Assay at 
560 nm 1
1 2.5 30 . -0.007
2 5 30 - - 0.001
3 1 0 30 - 0 . 0 1 2
4 2.5 30 + 0.000
5 5 30 + - 0.001
6 1 0 30 + -0.036
7 - - - 0.000
8 w ater b la n k - - 0.000
9 pos itive
con tro l
—► 2.372
Table 3.4.1. Optimisation of transfection using the polybrene method in the 
SW620 cells. T h is  table shows the e ffec t o f  va ry ing  the D N A  concentra tion  and the 
use o f  a g lyce ro l shock w h ile  keep ing the concentration o f  po lybrene constant at 30 
fig /m l. Sam ple 7, the negative co n tro l fo r  the transfection  procedure, was a sample o f  
S W 620 ce lls  w h ic h  were no t transfected. Sample 8 , the w a te r b la n k  was a negative 
con tro l fo r  the C PR G  assay. Sam ple 9, the pos itive  co n tro l in v o lv e d  incuba ting  
1.25ng o f  a com m erc ia l p repara tion  o f  the enzym e p-galactosidase in  the reaction  
m ix tu re . S ig n ifica n t absorbance readings (>0.3) are designated b y  an arrow .
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Sample DNA (fig) 
conc.
Polybrene (fig/ml) 
conc.
Glycerol
shock
CPRG 
Assay at 
560 nm
1 2.5 1 0 0.043
2 5 1 0 - 0.054
3 1 0 1 0 - 0.017
4 2.5 1 0 + 0.034
5 5 1 0 + 0 . 0 2 1
6 1 0 1 0 + 0.006
7 - - - 0 .0 0 0
8 w ater b lank - - 0 .0 0 0
9 pos itive
con tro l
-►  2.372
Table 3.4.2. Optimisation of transfection with polybrene. T h is  table shows the 
e ffec t o f  va ry in g  the D N A  concentra tion  and the use o f  a g lyce ro l shock w h ile  keeping 
the concentra tion  o f  po lybrene constant at 10 |ig /m l. Sam ple 7, the negative con tro l 
fo r  the transfection  procedure, was a sample o f  S W 620 ce lls w h ic h  were no t 
transfected. Sam ple 8 , the w ater b la n k  was a negative co n tro l fo r  the C P R G  assay. 
Sam ple 9, the pos itive  con tro l in vo lve d  incuba ting  1.25ng o f  a com m erc ia l 
p repara tion  o f  the enzyme (3-galactosidase in  the reaction  m ix tu re . S ig n ifica n t 
absorbance readings (>0.3) are designated b y  an arrow .
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Sample DNA Oig) 
conc.
Polybrene (pg/ml) 
conc.
Glycerol
shock
CPRG 
Assay at 
560 nm
1 2.5 5 . 0.028
2 5 5 - 0.032
3 1 0 5 - 0.041
4 2.5 5 + 0.023
5 5 5 + 0.005
6 1 0 5 + 0.058
7 - - - 0 .0 0 0
8 w ater b la n k - - 0 .0 0 0
9 pos itive —► 2.372
con tro l - -
Table 3.4.3. Optimisation of transfection with polybrene. T h is  table shows the 
e ffe c t o f  va ry in g  the D N A  concentra tion  and the use o f  a g lyce ro l shock w h ile  keep ing  
the concentra tion  o f  po lybrene constant at 5 p g /m l. Sample 7, the negative co n tro l fo r  
the transfection  procedure, was a sample o f  S W 620 ce lls w h ic h  w ere no t transfected. 
Sam ple 8 , the w ater b la n k  was a negative con tro l fo r  the C PR G  assay. Sam ple 9, the 
p o s itive  con tro l in vo lve d  incuba ting  1.25ng o f  a com m erc ia l prepara tion  o f  the 
enzym e p-galactosidase in  the reaction  m ix tu re . S ig n ifica n t absorbance readings 
(>0.3) are designated b y  an arrow .
62
3.4.1. Discussion
A s can be seen fro m  tables 3.4.1.-3.4.3. three concentrations o f  po lybrene were 
investigated, 30, 10 and 5 [ig /m l. I t  can be observed in  tables 3 .4 .1.-3 .4 .3. that 
samples 1 - 6  in  each table, resulted in  absorbance readings tha t corresponded to 
negative  P-galactosidase values, as a ll readings w ere < 0 . 1 1  (the P-galactosidase 
standard curve intercepts the y  axis at 0 . 1 1 , correspond ing to  0  ng o f  P-galactosidase). 
Absorbance readings >  0.3 (corresponding to  0.15 ng o f  P-galactosidase) are 
s ig n ifica n t readings as they denote that the ce lls were transfected s u ffic ie n tly  w ith  
p C H llO ,  fo r  transient transfection  assays (W ilso n  et al., 1995).
I t  was concluded that us ing po lybrene to  transfect the S W 620  ce lls was no t suitable. 
A t  th is  stage i t  was becom ing apparent that the S W 620 ce lls  were p ro v in g  to  be very 
resistant to  transfection  and therefore, tw o  other ce ll lines w ere investiga ted. These 
were the W iD r  and the SW 480, co lon  carcinom a ce ll lines. A s  m entioned in  the 
in tro d u c tio n  (section 1.5.), bo th  the W iD r  and the S W 620 c e ll lines express m a tr ily s in  
and so are suitable ce ll lines in  w h ic h  to  carry out transcrip tiona l co n tro l experim ents. 
The S W 480 ce ll lin e  does no t express m a trily s in  and so w o u ld  no t be a su itab le  ce ll 
lin e  to  ca rry  ou t the transcrip tiona l con tro l experim ents. T h is  ce ll lin e  was in c luded  in  
the transfection  o p tim isa tio n  experim ents, as lite ra tu re  was ava ilab le  docum enting  the 
use o f  the CaPC>4 m ethod, to  transfect the S W 480 ce ll line . Thus the S W 480 c e ll lin e  
co u ld  be used as a pos itive  co n tro l ce ll lin e  fo r  the C a P 0 4 m ethod.
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3.5. The C aP04 transfection method
O p tim isa tio n  experim ents us ing  th is  m ethod were carried  ou t in  the SW 620, W iD r  
and the S W 480 ce ll lines fo r  reasons m entioned in  section 3.4.1. T h is  m ethod is 
based on the o rig in a l w o rk  o f  G raham  and V an  der E b (1973), and in vo lve s  m ix in g  a 
Hepes bu ffe red  saline, D N A  and C aC l2 together under constant s tirr ing . Section
2.5.5. covers the experim enta l deta ils and section 1.4.3. an ove ra ll lo o k  at the 
technique. A  CaP0 4 -D N A  prec ip ita te  is fo rm ed  and is taken up b y  the ce lls  by 
endocytosis.
There is a w ide  v a r ia b ility  in  the re ce p tiv ity  o f  a g iven  c e ll type to  transfec tion  b y  th is  
technique. Fo r some c e ll types, th is  m ethod causes a h ig h  percentage o f  transfo rm ed 
cells, whereas, fo r  others i t  has a n eg lig ib le  e ffect. The m a in  variab les to  op tim ise  
inc lude  the am ount o f  D N A , the leng th  o f  tim e  the p rec ip ita te  is  le f t  on the ce lls, and 
w hether o r no t a g lyce ro l shock is used to a id  entry o f  the D N A  in to  the ce lls. The 
results o f  the CaP0 4  op tim isa tio n  experim ents in v o lv in g  the SW 620, the W iD r ,  and 
the S W 480 ce ll lin e  can be observed in  table 3.5.1., 3.5.2, and 3.5.3 respective ly .
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Sample DNA Gig) 
conc.
Incubation  
Time (hr)
Glycerol
Shock
CPRG Assay 
Abs. at 560 nm
1 1 0 4 -0 .0 0 1
2 2 0 4 - -0.005
3 30 4 - -0 .0 0 1
4 40 4 - 0 .0 0 0
5 50 4 - 0 .0 0 2
6 60 4 - 0.007
7 10 8 - 0.003
8 2 0 8 - 0 .0 0 0
9 30 8 - -0 .0 0 2
1 0 40 8 - -0 .004
11 50 8 - -0 .0 0 1
1 2 60 8 - -0.005
13 r 16 - -0 .0 0 2
14 2 0 16 - -0 . 0 0 1
15 30 16 - 0 .0 0 0
16 40 16 - 0 .0 0 2
17 50 16 - 0.006
18 . . . . 0.008
19 1 0 24 - 0.003
2 0 2 0 24 - 0 .0 0 0
2 1 30 24 - 0 . 0 0 1
2 2 40 24 - -0 .0 0 0
23 50 24 - -0 .0 0 2
24 24 _ 0.005
25 - 0 .0 0 0
26 w ater b la n k - - 0 .0 0 0
27 pos itive - - 2.612 «--------
con tro l
Table 3.5.1. Optimisation o f the C aP 0 4  method in the S W 620  cells. T h is  table
shows the e ffec t o f  va ry ing  the D N A  concentration and also the am ount o f  tim e  the 
p rec ip ita te  was le ft  on the cells. The above was also repeated w ith  a g lyce ro l shock 
and the same results were obtained. Sam ple 25, the negative co n tro l fo r  the 
transfection  procedure, was a sample o f  S W 620 ce lls  w h ich  were no t transfected. 
Sam ple 26, the w ater b la n k  was a negative co n tro l fo r  the C PR G  assay. Sam ple 27, 
the pos itive  co n tro l in vo lve d  incubating  1.25ng o f  a com m erc ia l prepara tion  o f  the 
enzym e P-galactosidase in  the reaction  m ix tu re . S ig n ifica n t absorbance readings 
(>0.3) are designated by  an arrow .
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Sample DNA(ng)
conc.
Incubation 
Time (hr)
Glycerol
Shock
CPRG Assay 
Abs.at 560 nm ,
1 2 4 _ -0.008
2 5 4 - -0.007
3 1 0 4 - -0.008
4 15 4 - -0.003
5 2 0 4 - -0.003
6 40 4 - -0.008
7 2 4 + -0.003
8 5 4 + 0 .0 0 1
9 1 0 4 + 0 .0 0 2
1 0 15 4 + 0.004
1 1 2 0 4 + 0.000
n 10 4 ■ -0  oos
13 2 16 -0.027
14 5 16 - 0.007
15 1 0 16 - -0.003
16 15 16 - 0.009
17 2 0 16 - 0.015
18 40 .6 _ 0.006
19 2 16 + 0.007
2 0 5 16 + 0.003
2 1 1 0 16 + 0.004
2 2 15 16 + 0 .0 0 2
23 2 0 16 + -0 . 0 1 2
24 4. + ,0 0 9
25 0.000
26 w ate r b la n k - - 0.000
27 pos itive - - 2.612 4--------
con tro l
Table 3.5.2. Optimisation of the CaP04 method in the WiDr cells. T h is  table 
shows the e ffec t o f  va ry ing  the D N A  concentra tion , the use o f  a g lyce ro l shock and 
also the am ount o f  tim e  the p rec ip ita te  was le f t  on the cells. Sample 25, the negative 
co n tro l fo r  the transfection  procedure, was a sample o f  W iD r  cells w h ic h  w ere no t 
transfected. Sample 26, the w ater b lank  was a negative co n tro l fo r  the C PR G  assay. 
Sam ple 27, the pos itive  con tro l in vo lve d  incuba ting  1.25ng o f  a com m erc ia l 
p repara tion  o f  the enzym e (3-galactosidase in  the reaction  m ix tu re . S ig n ific a n t 
absorbance readings (>0.3) are designated b y  an arrow .
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Sample DNA(pg)
conc.
Incubation 
Time (hr)
Glycerol
Shock
CPRG Assay 
Abs.at 560 nm
1 2 4 _ - 0 . 0 1 0
2 5 4 - 0.005
3 1 0 4 - 0.006
4 15 4 - 0.144
5 2 0 4 - 0.214
6 40 4 - 1.299 <-----------
7 2 4 + -0.016
8 5 4 + 0.018
9 1 0 4 + 0.307 <-----------
1 0 15 4 + 0.406 <-----------
1 1 2 0 4 + 0.960 <-----------
19 40 - . O *
13 2 16 -0.003
14 5 16 - -0 .006
15 1 0 16 - 0.028
16 15 16 - 0.038
17 2 0 16 - 0.078
18 .. 16 - 0.194
19 2 16 + 0.107
2 0 5 16 + 0.156
2 1 1 0 16 + 0.067
2 2 15 16 + 0.015
23 2 0 16 + 0.166
24 . 0,194
25 0 .0 0 0
26 w ater b lank - - 0 .0 0 0
27 pos itive - - 2.612 4-------------
con tro l
Table 3.5.3. Optimisation o f the CaP04 method in the SW 480 cells. T h is  table 
shows the e ffec t o f  va ry ing  the D N A  concentra tion , the use o f  a g lyce ro l shock and 
also the am ount o f  tim e  the precip ita te  was le ft on the cells. Sample 25, the negative 
con tro l fo r  the transfection  procedure, was a sample o f  S W 480 ce lls w h ic h  were no t 
transfected. Sam ple 26, the w ater b lank  was a negative con tro l fo r  the C P R G  assay. 
Sample 27, the pos itive  con tro l in vo lve d  incuba ting  1.25ng o f  a com m erc ia l 
preparation o f  the enzym e P-galactosidase in  the reaction  m ix tu re . S ig n ifica n t 
absorbance readings (>0.3) are designated b y  an arrow .
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3.5.1. Discussion
A  w ide  range o f  D N A  concentrations w ere used in  the CaPC>4 trans fec tion  
op tim isa tion  experim ents. Table 3.5.1. shows the results obta ined w hen 4, 8 , 16, and 
24 h r incubations were used w ith o u t a g lyce ro l shock, on the S W 620 ce ll line . A s  can 
be seen fro m  the data samples 1-24, resulted in  absorbance readings tha t corresponded 
to  negative P-galactosidase values, as a ll readings were < 0 . 1 1  (the P-galactosidase 
standard curve intercepts the y  axis at 0 . 1 1 , correspond ing to  0  ng o f  P-galactosidase). 
Absorbance readings >  0.3 (corresponding to  0.15 ng o f  P-galactosidase) are 
s ign ifican t readings as they denote that the ce lls w ere transfected s u ffic ie n tly  w ith  
p C H l 10, fo r  transient transfection  assays (W ilso n  et al., 1995).
Th is  experim ent was also repeated w ith  a g lyce ro l shock. A ga in , the absorbance 
readings that were obta ined corresponded to  negative P-galactosidase values, as a ll 
readings were < 0 . 1 1  (the P-galactosidase standard curve intercepts the y  axis at 0 . 1 1 , 
correspond ing to  0 ng o f  P-galactosidase). W e  concluded fro m  th is  tha t the CaPC>4 
transfection  technique cou ld  not be used to transfect the S W 620 c e ll line .
Table 3.5.2. illus tra tes  the results obta ined w hen the CaPCU transfec tion  o p tim isa tio n  
was carried  out on the W iD r  ce ll line . A s can be seen fro m  the tab le  the resu lts  are 
s im ila r to  those obta ined fo r  the S W 620 ce ll line . The tab le  shows the results 
obtained w hen a 4 h r incuba tion  was carried  out w ith  and w ith o u t a g lyce ro l schock 
and w hen a 16 h r incuba tion  was used w ith  and w ith o u t a g lyce ro l shock. The 8  and 
24 h r incubations w ith  and w ith o u t g lyce ro l shocking were also carried  ou t b u t these 
varia tions d id  no t resu lt in  any transfected ce lls, as a ll the absorbance readings 
obtained corresponded to  negative P-galactosidase values, as a ll the readings were 
<0 .11.
Table 3.5.3. illus tra tes the results obta ined w hen a range o f  D N A  am ounts were 
transfected in to  the S W 480 ce ll line  us ing  a 4 and 16 h r incuba tion  w ith  and w ith o u t a 
g lyce ro l shock. The lo w e r concentrations fo r  the 4 h r incuba tio n  w ith o u t a g lyce ro l 
shock d id  no t resu lt in  any transfected ce lls  as a ll the absorbance readings obta ined 
were < 0 . 1 1 (samples 1-3). P-galactosidase expression was detected in  sample 4, w ith  
the use o f  15 (Jg o f  D N A  (0.144 O .D ., using a P-galactosidase standard curve 
illu s tra ted  on p52, th is  absorbance reading corresponded to  0.018 ng o f  P-
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galacosidase). W hen  20 jxg and 40 (ig  o f  D N A  were used under these cond ition s  the 
cells were transfected resu lting  in  a (3-galacosidase expression o f  0.056 (0 .214 O .D .) 
and 0.644 (1.299 O .D .) ng respective ly (samples 5 and 6 ). Sam ple 6  was the o n ly  
sample fro m  the 4  h r incuba tion  w ith o u t a g lyce ro l shock group, tha t resu lted  in  
s ig n ifica n t absorbance readings. Absorbance readings >  0.3 (corresponding to  0.15 ng 
o f  (3-galactosidase) are s ign ifican t readings as they denote tha t the ce lls  were 
transfected s u ffic ie n tly  w ith  p C H llO , fo r  transient transfection  assays (W ils o n  et al., 
1995).
I f  the results are com pared to  those obta ined when a 4 h r incuba tion  w ith  a g lyce ro l 
shock was used, a dram atic  change is observed. T h is  is due to the e ffec t o f  the 
g lyce ro l shock used. Samples 9-12 a ll resulted in  s ig n ifica n t absorbance readings 
(readings a ll >0 .3 ) denoting that the cells were s u ffic ie n tly  transfected w ith  p C H llO ,  
fo r  transient transfec tion  assays.
As can be seen fro m  table 3.5.3. the use o f  a 16 h r incuba tion  w ith o u t a g lyce ro l shock 
was no t very e ffec tive . A  lo w  le ve l o f  transfection  was observed, (0.045 ng o f  (3- 
galactosidase, 0.194 O .D .) w ith  40 | ig  o f  p C H llO  (sam ple 18). In  com parison, 
g lyce ro l shock ing  the ce lls  after a 16 h r incuba tion  m a rg in a lly  im p roved  transfection , 
but i t  d id  not have the dram atic e ffec t tha t was observed w hen the ce lls  were g lyce ro l 
shocked after a 4  h r incubation.
The e ffec t o f  an 8 and 24 h r incuba tion  were also investigated. The results obta ined 
fro m  the 8 h r in cuba tio n  were s im ila r to those obta ined w ith  the 16 h r incuba tion . The 
24 h r incuba tion  d id  no t y ie ld  any transfected cells. I t  can be concluded fro m  these 
results that a 4 h r incuba tion  w ith  a g lyce ro l shock and 20 |Xg o f  D N A  are the 
op tim u m  cond itions  fo r  the C a P 0 4 transfection  o f  the S W 480 ce ll line . Even though  
40 ng  o f  D N A  resulted in  a h igher le ve l o f  transfection , 20 (ig  w o u ld  be m ore than 
su ffic ie n t to  use. F igu re  3.8.4. (b) illus tra tes a photograph o f  the S W 480 cells 
transfected under these op tim um  cond itions  and stained using the in-situ stain 
described in  section 2.6.4.
These transfection  experim ents carried out in  the S W 480 ce ll lin e  c lea rly  established 
that the transfection  p ro to co l was co rrec tly  carried  out. Even though th is  m ethod was 
e ffec tive  in  trans fec ting  the S W 480 ce ll lin e , th is  ce ll lin e  cou ld  no t be used in  
transcrip tiona l regu la tion  experim ents, since i t  does no t express m a tr ily s in  n o r can i t
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be stim ula ted w ith  g row th  factors to  overexpress m a tr ily s in  (G aire  et al., 1994). The 
next transfection  m ethod investigated was the e lectropora tion  m ethod.
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3.6. Optimisation of the electroporation method
Experiments investigating the use of electroporation were carried out on the SW 620, 
W iD r and SW 480 cell lines. Transfection by electroporation is based on the 
administration of a brief high voltage electric pulse which causes momentary pores in 
the cell membrane through which DNA can enter, (Neumann et al., 1982, 
Zimmermann et al., 1982).
Electroporation is most dependent on the applied electric field (E), and the field is 
related to the voltage (V) and the distance (d) by the equation E=v/d. The m ost 
important factors to optimise are the field strength and the duration o f the electric 
pulse. These two factors can be varied by adjusting the voltage and the capacitance 
respectively. For more background details consult section 1.4.4. and for the precise 
method section 2.5.6. Three capacitance values were investigated in these 
experiments, namely 25, 500 and 960 pF. W hen the higher capacitances (500 and 960 
pF) were used, the equipment did not allow any voltages higher than 0.46 kV to be 
applied.
The results of the electroporation experiments on the SW 620 cell line can be seen in 
table 3.6.1., on the W iDr cell line in table 3.6.2. and the results on the SW 480 cell line 
in table 3.6.3.
71
Sample Voltage
(kV)
Capacitance
m
CPRG Assay 
Abs at 560 nm
1 0.260 25 0.006
2 0.460 25 0.018
3 0.660 25 0.007
4 0.860 25 0.004
5 1.060 25 0.003
6 1.260 25 0.003
7 1.470 25 0.000
8 0 .210 500 -0.002
9 0.260 500 - 0.001
10 0.310 500 0.003
1 1 0.360 500 0.003
12 0.410 500 0.006
13 0.430 500 0.005
14 . .. . ........... 0 004
15 0 .210 960 0.002
16 0.260 960 0.001
17 0.310 960 0.001
18 0.360 960 -0.003
19 0.410 960 0.004
20 0.430 960 0.002
21 - -0.002
2 2 water blank 0.000
23 Neg. Con. - 0.000
24 Pos. Con. - 1.947 <
Table 3.6.1. Optimisation of the electroporation transfection method with the 
SW620 cells. This table shows the effect o f varying the voltage and the pulse applied 
to the cells. The amount of DNA used was kept constant at 10 jug. Sample 22, the the 
water blank was a negative control for the CPRG assay. Sample 23 the negative 
control for the transfection procedure, was a sample of SW 620 cells which were not 
transfected. Sample 24, the positive control involved incubating 1.25ng of a 
commercial preparation of the enzyme (3-galactosidase in the reaction mixture. 
Significant absorbance readings (>0.3) are designated by an arrow.
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Sample Voltage
(kV)
Capacitance
m
CPRG Assay 
Abs at 560 nm
1 0.260 25 -0.002
2 0.460 25 - 0.001
3 0.660 25 0.003
4 0.860 25 0.003
5 1.060 25 0.006
6 1.260 25 0.005
7 1.470 25 0.004
8 0 .210 500 0.002
9 0.260 500 0.006
10 0.310 500 0.018
11 0.360 500 0.007
12 0.410 500 0.004
13 0.430 500 0.003
14 0 460 . . . OOO^
15 0 .210 960 0.000
16 0.260 960 0.003
17 0.310 960 - 0.001
18 0.360 960 -0.003
19 0.410 960 -0.004
20 0.430 960 - 0.001
21 0.460 960 0.006
22 water blank - 0.000
23 Neg. Con. - 0.000
24 Pos. Con. “
r-°qi-H
Table 3.6.2. Optimisation of the electroporation transfection method with the 
WiDr cells. This table shows the effect of varying the voltage and the pulse applied 
to the cells. The amount of DNA used was kept constant at 10 |ig. Sample 22, the the 
water blank was a negative control for the CPRG assay. Sample 23 the negative 
control for the transfection procedure, was a sample of W iDr cells which were not 
transfected. Sample 24, the positive control involved incubating 1.25ng of a 
commercial preparation o f the enzyme P-galactosidase in the reaction mixture. 
Significant absorbance readings (>0.3) are designated by an arrow.
73
Sample Voltage
(kV)
Capacitance
m
CPRG Assay 
Abs at560 nm
1 0.260 25 0.075
2 0.460 25 -0.039
3 0.660 25 0.039
4 0.860 25 -0.027
5 1.060 25 0.189
6 1.260 25 -0.009
7 1.470 25 0.018
8 0 .2 10 500 -0.002
9 0.260 500 0.009
10 0.310 500 -0.003
1 1 0.360 500 -0 .0 21
12 0.410 500 0.018 1
13 0.430 500 0.003
14 0 460 SOO 0.003
15 0 .2 10 960 0.009
16 0.260 960 -0.003
17 0.310 960 -0.0 21
18 0.360 960 0.018
19 0.410 960 0.003
20 0.430 960 0.000
2 1 0.460 960 0.003
2 2 water blank - 0.000
23 Neg. Con. - 0.000
24 Pos. Con. “ 2.020  «-------
Table 3.6.3. Optimisation of the electroporation transfection method with the 
SW480 cells. This table shows the effect of varying the voltage and the pulse applied 
to the cells. The amount of DNA used was kept constant at 10 (ig. Sample 22, the the 
water blank was a negative control for the CPRG assay. Sample 23 the negative 
control for the transfection procedure, was a sample of SW 480 cells which were not 
transfected. Sample 24, the positive control involved incubating 1.25ng of a 
commercial preparation o f the enzyme [3-galactosidase in  the reaction mixture. 
Significant absorbance readings (>0.3) are designated by an arrow.
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3.6.1. Discussion
These electroporation experiments were carried out using 10 pg of DNA and 5 x 106 
cells. Three capacitance values were investigated in these experiments, namely 25, 
500 and 960 (iF. These affected the duration of the pulse applied. The time of each of 
the pulses was also recorded. A 1.1 msec pulse was applied when a capacitance o f 25 
pF was used. A 19 and a 38 msec pulse were applied when capacitances o f 500 and 
960 pF  were used.
As can be seen from table 3.6.1. the different pulses applied to the SW 620 cells did 
not result in any transfected cells as all the absorbance readings corresponded to 
negative P-galactosidase values, as all readings were <0.11 (the P-galactosidase 
standard curve intercepts the y axis at 0 .1 1 , corresponding to 0 ng o f (3-galactosidase). 
Absorbance readings > 0.3 (corresponding to 0.15 ng o f P-galactosidase) are 
significant readings as they denote that the cells were transfected sufficiently with 
pC H l 10, for transient transfection assays (Wilson et al., 1995).
This was also the case for the W iDr cell line. One of the pulses applied to the SW 480 
cells resulted in a low level o f transfection, which was not sufficient for transient 
transfection assays as the O.D. reading was <0.3. This was sample 5 which had an 
absorbance reading of 0.189. This reading corresponds to a 0.04 ng expression of p- 
galactosidase, in 10  p i of this sample cell extract, (total volum e o f cell extract is 60 
pi). This level of P-galactosidase expression was obtained by using the P- 
galactosidase standard curve. If this level of P-galactosidase expression, 0.04 ng in 
sample 5 from  table 3.6.3., is compared to that obtained when the SW 480 cells are 
transfected using the CaP04  method, (0.4 ng of P-galactosidase), under optimum 
conditions, sample 20 from table 3.5.3., it can be seen that the CaP04 method is 10 
times more effective at transfecting the SW480 cells than the electroporation method.
It can be concluded from  these results that the electroporation method is not suitable 
for transfecting the SW 620 and W iD r cell lines and also this method results in a low 
level of transfection of the SW 480 cell line when a capacitance o f 25 pF and a voltage 
of 1.060 kY is used. The next set of experiments dealt with investigating the use of 
lipofection to transfect a suitable cell line.
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3.7. Transfection using Lipofectamine
The use of a cationic lipid such as lipofectamine to transfect cells is known as 
lipofection. Optimum transfection efficiency occurs when the ratio of positively 
charged molar equivalents (contributed by the cationic lipid), is nearly equivalent to 
the number of molar equivalents o f negative charge contributed by the polynucleotide, 
(Feigner et al., 1993). The lipofectamine reagent used was a 3:1 (w/w) liposome 
formulation of the polycationic lipid DOSPA and the neutral lipid DOPE in 
membrane filtered water from Gibco / BRL. More inform ation on lipofection can be 
found in section 1.4.5. and the method used in section 2.5.7.
The effectiveness of lipofectamine to transfect the W iDR, SW 620, and the SW 480 
cell line was investigated. The results of these experiments can be found in tables 
3.7.1., 3.7.3. respectively.
Sample DNA Qig) 
conc.
lipofectamine
(Ml)
C P R G  Assay 
Abs. At 560 nm
1 0.5 20 0 .0 12
2 1.0 20 0.003
3 2.5 20 -0.002
4 3.0 20 -0.005
5 5.0 20 0.008
6 10.0 20 0.006
7 water blank - 0.000
8 Neg. Con. - 0.000
9 Pos. Con. - 2.300 <
Table 3.7.1. Optimisation of transfection using the lipofectamine method in the 
WiDr cells. This table shows the effect of varying DNA concentration, using the 
lipofectamine method. Sample 7, the the water blank was a negative control for the 
CPRG assay. Sample 8 the negative control for the transfection procedure, was a
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sample of W iDr cells which were not transfected. Sample 9, the positive control 
involved incubating 1.25ng o f a commercial preparation o f the enzyme (3- 
galactosidase in the reaction mixture. Significant absorbance readings (>0.3) are 
designated by an arrow.
Sample DNA (ng) 
conc.
lipofectamine C PR G  Assay 
Abs. At 560 nm
1 0.5 20 0.010
2 1.0 20 0.003
3 2.5 20 -0.006
4 3.0 20 -0.005
5 5.0 20 0.016
6 10.0 20 0.016
7 water blank - 0.000
8 Neg. Con. - 0.000
9 Pos. Con. - 1.875 <—
Table 3.7.2. Optimisation of transfection using the lipofectamine method in the 
SW620 cells. This table shows the effect of varying DNA concentration, using the 
lipofectamine method. Sample 7, the the water blank was a negative control for the 
CPRG assay. Sample 8 the negative control for the transfection procedure, was a 
sample of SW 620 cells which were not transfected. Sample 9, the positive control 
involved incubating 1.25ng of a commercial preparation of the enzyme (3- 
galactosidase in the reaction mixture. Significant absorbance readings (>0.3) are 
designated by an arrow.
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Sample DNA(pg)
conc.
lipofectamine
(nD
CPRG Assay 
Abs. At 560 nm
1 0.5 20 0.003
2 1.0 20 0.006
3 2.5 20 -0.0 10
4 3.0 20 -0.004
5 5.0 20 0.016
6 10.0 20 0.336 4-------
7 water blank - 0.000
8 Neg. Con. - 0.000
9 Pos. Con. - 1.855 <-------
Table 3.7.3. Optimisation of transfection using the lipofectamine method in the 
SW480 cells. This table shows the effect of varying DNA concentration, using the 
lipofectamine method. Sample 7, the the water blank was a negative control for the 
CPRG assay. Sample 8 the negative control for the transfection procedure, was a 
sample o f SW 480 cells which were not transfected. Sample 9, the positive control 
involved incubating 1.25ng o f a commercial preparation o f the enzyme p- 
galactosidase in the reaction mixture. Significant absorbance readings (>0.3) are 
designated by an arrow.
3.7.1. Discussion
W hen using the lipofectamine procedure to transfect cells, it is recommended that a 
fixed volume of 20 jll of lipofectamine is used while a range o f DNA concentrations 
are tested. The incubation of the transfection mixture with the cells is kept constant at 
5 hr. This procedure is prohibitively expensive (approximately £12 per transfection 
plate) and can only be used in serum-free media.
As can be seen from tables 3.7.1. and 3.7.2. the lipofectamine procedure was not 
successful in transfecting the SW 620 or the W iDr cell line. It was however suitable
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for transfecting the SW 480 cell line, (see table 3.7.3.)- A 20 |Xl volum e of 
lipofectamine and 10 |ig of DNA resulted in an absorbance reading o f 0.336 (this 
corresponded to a 0 .12 2  ng level of (3-galactosidase expression, calculated from a P- 
galactosidase standard curve) in a 10 (0,1 of cell extract, (total cell extract volum e 30 
pi). This was not further optimised as we were only using the SW 480 cell line as a 
positive control cell line as it can be readily transfected. This result was repeated and 
the plate was stained using the in-situ stain, of which a photograph can be seen in 
figure 3.8.4. (c).
It was concluded that the lipofectamine method was not suitable for transfecting the 
SW 620 and the W iDr cell lines. It was also concluded that these two cell lines were 
proving impossible to transfect. It was decided to take a look at transfecting another 
cell line the A549 cell line which is not a colon carcinoma cell line but a lung 
adenocarcinoma cell line. This cell line has been shown to endogenously express 
matrilysin mRNA (Fingleton 1995). Unpublished results from  this laboratory had 
demonstrated that matrilysin mRNA expression could be stimulated in this cell line by 
EGF and cytokines and therefore would be suitable to investigate the transcriptional 
regulation of matrilysin gene expression.
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3.8. The use of DOTAP in transfection experiments
This liposome formulation is available from Boehringer M annheim. As a lipid 
formulation it is very easily metabolised by cells in culture than other formulations 
and therefore less toxic to the cells. It also has an added advantage in that it can be 
used with serum if  necessary whereas components present in serum can affect 
transfection o f cells using m ost other lipid formulations (W alker et al., 1992). 
Optimisation experiments were carried out in the A549 cell line, (see section 2.5.8. for 
details on method). The results of the experiments carried out in the A549 cell line in 
figures can be found in figures 3.8.1-3.8.3.
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Figure 3.8.1. Optimisation of the DNA:DOTAP ratio for the A549 cell line. This 
figure shows the effect o f varying the DNA:DOTAP ratio. The quantity of DNA  was 
kept constant at 5 (ig. Levels of (3-galactosidase >0ng represent transfected cells. 
Levels of (3-galactosidase >0.15 ng are significant, as they denote an adequate level of 
transfection for transient transfection assays.
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Figure 3.8.2. Optimisation of DNA concentration for the A549 cell line. This 
figure shows the effect of varying the DNA concentration. The ratio of DNA:DOTAP 
was kept constant at 1:3. Levels of (3-galactosidase >0ng represent transfected cells. 
Levels of P-galactosidase >0.15 ng are significant, as they denote an adequate level of 
transfection for transient transfection assays.
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Figure 3.8.3. Optimisation of DNA concentration for the A549 cell line. This 
figure shows the effect of varying the DNA concentration. The ratio of DNA:DOTAP 
was kept constant at 1:4. Levels of (3-galactosidase >Ong represent transfected cells. 
Levels of (3-galactosidase >0.15 ng are significant, as they denote an adequate level of 
transfection for transient transfection assays.
3.8.1. Discussion
Figure 3.8.1. shows the results of a DOTAP transfection optimisation experim ent 
carried out on the A549 cell line. All o f the various DNA:DOTAP ratios tested 
resulted in transfected cells as all levels o f [3-galactosidase expression were >0  ng. 
However none of the levels of [3-galactosidase expression were significant (as they 
were all <0.15 ng of (3-galactosidase) for carrying out transient transfection assays so 
further optimisation experiments was carried out. There was a gradual increase in the 
number of transfected cells as the DNA:DOTAP ratio increased. This number of 
transfected cells reached a maximum at the 1:3 and 1:4 ratios before starting to 
decline again. Further optimisation was then carried out with the ratios that had
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resulted in maxim um  levels of transfected protein i.e. the 1:3 and 1:4 ratios. This 
further optimisation involved keeping the DNA:DOTAP ratio constant and varying 
the DNA concentration from 2.5 to 20 pg. The results o f this optimisation for the 1:3 
ratio can be seen in figure 3.8.2. and for the 1:4 ratio in figure 3.8.3. 2.5 pg o f DNA 
did not result in any level of P-galactosidase expression, the protein product of the 
transfected gene, for either of the DNA:DOTAP ratios being investigated. The next 
concentration of DNA, 5 pg produced a similar result for both o f the ratios being 
investigated, 0.075 ng for the 1:3 ratio and 0.055 ng of (3-galactosidase for the 1:4 
ratio. This result is in keeping with those obtained in the original optimisation 
experiment where 5 pg of DNA resulted in a 0.075 ng level o f (3-galactosidase 
expression for the 1:3 ratio and a 0.073 ng level o f (3-galactosidase expression for the 
1:4 ratio. The level o f expression of (3-galactosidase in the rest of the samples from  
the 1:3 DNA:DOTAP ratio peaked at 10 pg of DNA, with 0.096 ng o f (3-galactosidase 
being expressed. This then dropped to 0.062 ng for 15 pg of DNA and then to 
practically zero, (0.001 ng) for 20 pg of DNA. None of the levels of transfected (3- 
galactosidase reached significance for transient transfection assays as all the levels of 
P-galactosidase expression were <0.15 ng.
This was not the case for the rest of the samples from  the 1:4 DNA:DOTAP group. 
The level o f (3-galactosidase expression rose to m uch higher levels for 10 and 15 pg of 
DNA reaching 0.196 and 0.198 ng respectively, which were significant levels of (3- 
galactosidase expression for transient transfection assays as these levels are >0.15 ng. 
The level of p-galactosidase expression then decreased for the 20 pg o f DNA sample, 
to 0.141 ng level o f P-galactosidase.
In conclusion, the optimal conditions for transfection of the A549 cell line using 
DOTAP were, a concentration of 10 pg of DNA, and a DNA:DOTAP ratio o f 1:4 
produces a level o f expression of P-galactosidase, (0.196 ng, O.D. reading of 0.473 in 
a 10  p i sample of extract, total volume 60 pi), which would be sufficient for transient 
transfection assays. A  photograph of the A549 cells transfected by DOTAP can be 
found in figure 3.8.4. (d).
Having successfully demonstrated that the A549 cell line could be transfected using 
the cationic lipid DOTAP the transcriptional regulation of matrilysin gene expression 
was investigated.
83
Method SW620 WiDr SW480 A549
DEAE-dextran _(3) ND(b) ND ND
Glass Beads - N S(C) NS NS
Polybrene - ND ND ND
CaP04 - - ++++(d) ND
Electroporation - •r + ND
Lipofectamine ~ - ++ ND
DOTAP ND ND ND +++
Table 3.8.2. Comparison of transfection methods in human cancer cell lines
(a) Negative results
(b) ND; Not determined
(c) NS; Not suitable, as cells detached from surface of plate
(d) + Positive results, +=0.04 n g ,++=0.117 n g ,+++=0.196 ng,
++++=0.460 ng of (3-galactosidase
This table summarises the results o f all the transfection experiments carried out. As 
can be seen from  the table a suitable transfection method for the SW 620 and W iDr 
cell lines was not found. The SW480 cell line could be successfully transfected by a 
number of methods including the CaP0 4 , the electroporation, and the lipofectamine 
methods. O f these the CaP04 method yielded the highest level o f P-galactosidase 
expression. As can be seen from the table the A549 cell line was successfully 
transfected by the DOTAP method.
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(a) (b)
(c) (d)
Figure 3.8.4. In-situ staining of transfected cells, (a) SW 480 cells which are not 
transfected, (b) SW 480 cells transfected by CaPCU, (c) SW 480 cells transfected by 
lipofectamine and (d) A549 cells transfected by DOTAP. Transfected cells stain blue.
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3.9. Investigating the transcriptional regulation of matrilysin gene expression
The transcriptional regulation of matrilysin gene expression was investigated in the 
A549, a human lung adenocarcinoma cell line, since this cell line endogenously 
expresses matrilysin (Fingleton 1995). It can also be stim ulated with growth factors 
and cytokines to overexpress matrilysin and can be transfected w ith the cationic lipid 
DOTAP.
Sequence analysis has shown that various transcription regulatory elements are 
present w ithin the matrilysin promoter, including the AP-1 and PEA3 m otifs (Gaire et 
al., 1994). These regulatory sequences, in the collagenase and stromelysin promoters, 
have been shown to transactivate EGF and TPA regulation o f collagenase and 
stromelysin (for further details consult section 1.3) In order to identify these 
regulatory sequences as functional regulatory elements in the m atrilysin promoter, 
various segments of the matrilysin promoter were linked to the CAT m arker gene, 
which is easily assayable following transfection. This was carried out by our 
collaborators in Nashville. Four matrilysin CAT promoter constructs were made 
(Gaire et al., 1994). The p-95HPCAT construct contains the TATA and AP-1 
regulatory sequences. The p-295HPCAT construct encompasses these sequences plus 
the PE A3 motifs and the p-933HPCAT construct includes those sequences present in 
the p-295HPCAT construct plus additional TGF(3 inhibitory elements (TIE) 
sequences. The p-4.2HPCAT construct spans 4.2 Kbp of the matrilysin prom oter and 
it contains all the above mentioned sequences. Transfecting these constructs into the 
A549 cell line and stimulating with EGF and TPA would enable a determination as to 
whether or not the matrilysin gene is regulated by EGF and TPA  to be made and if so 
through which cis-acting elements they are exerting their effect. If  EGF or TPA  had a 
stimulatory effect on the matrilysin promoter, it will activate the prom oter causing the 
3 ’-flanking CAT gene to be transcribed. The amount of CAT produced is directly 
proportional to the regulatory effect that the particular factor has on the promoter. 
W hichever construct showed the greatest stimulation of the promoter, that is the 
largest amount o f CAT production, would tell us that it is in that region of the 
promoter that EGF or TPA is exerting its effect.
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Before proceeding with this experiment it was first necessary to optimise the 
conditions under which the A549 cells were stimulated. Prior to stimulation, the cells 
were fed with serum-free medium. This was necessary as growth factors naturally 
present in the serum may interfere in these experiments. Feeding the cells with 
serum-free medium before stimulation with the regulatory factors being investigated, 
ensures that any regulatory effects observed are due to the factors being investigated 
and not any components in the serum. The length of time the cells were stimulated 
also had to be investigated. In order to optimise the length o f time the cells were 
incubated in serum-free medium and the duration of the stimulation, transfection 
experiments varying these parameters using the pCM VCAT plasmid, which codes for 
the bacterial protein chloramphenicol acetyltransferase, were carried out. The 
pCM VCAT plasm id contains the cytomegalovirus (CMY) prom oter linked to the 
CAT gene. This plasmid serves as a positive control as the CMV prom oter is a 
constitutive promoter which enables endogenous expression o f the gene it is linked to 
in all cells (Reese et al., 1992). The amount of CAT produced was assayed using a 
CAT ELISA. The standard curve for the ELISA can be found in figure 3.9.1. The 
results of the stimulation optimisation are illustrated in figure 3.9.2. Once the 
stimulation step had been optimised we could then transfect the matrilysin promoter 
constructs and the pC H llO  plasmid, to normalise for variations in transfection 
efficiency, into the A549 cells, stimulate with EGF (5 ng/ml) and TPA (100 ng/ml) 
and then assay for CAT production using the CAT ELISA. The results of this 
experiment can be found in table 3.9.1.
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A b  s 
n m
CAT (pg)
Figure 3.9.1. CAT ELISA standard curve
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1 2 3 4 5 6
S a m p le  V a r ia tio n s
Sample 1 Total transfection carried out in D M E M So, no E G F  stimulation
Sample 2 Total transfection carried out in D M E M So, 24  hr E G F  stimulation
Sample 3 Transfection carried out in D M E M S 5 , no E G F  stimulation
Sample 4 Transfection carried out in D M E M S 5 , 8 hrs serum-free, 24 hr
E G F  stimulation
Sample 5 Transfection carried out in DMEMS5, no EGF stimulation
Sample 6 Transfection carried out in DMEMS5, 24 hr serum-free, 8 hr
EGF stimulation
Figure 3.9.2. Optimisation of stimulation conditions. This figure shows the effect 
o f variations in the length of time serum-free media (D M E M So) is incubated with the 
A549 cells transfected w ith the pCM VCAT plasmid and in the length of time EGF (5 
ng/ml) is subsequently left to stimulate these cells. D M E M S 5 denotes D M E M  
supplemented with 5% FCS.
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Sample Description CAT ELISA 
Abs. at 405 nm
CPRG Assay 
Abs. at 560 nm
1 p-95HPC AT-basai -0.038 0.473
2 P-95HPCAT-EGF -0.031 0.474
3 P-95HPCAT-TPA -0.010 0.463
4 p-295HPCAT-basal -0.002 0.395
5 P-295HPCAT-EGF -0.035 0.354
6 P-295HPCAT-TPA -0.024 0.481
7 p-933HPCAT-basal -0.028 0.461
8 P-933HPCAT-EGF -0.015 0.481
9 p-93 3HPC AT-TP A -0.038 0.395
1 10 p-4.2HPCAT-basal -0.041 0.387
1 1 p-4. 2HPC AT-EGF -0.052 0.471
12 P-4.2HPCAT-TPA -0.033 0.476
13 pFLCAT (neg. con.) -0.001 0.435
14 pCM VCAT (pos. con.) 0.845 0.389
15 W ater Blank -0.002 0.000
16 Neg. Con. (A549 cells) 0.000 0.000
17 Pos. Con. (20 pg CAT) 0.436 «
Table 3.9.1. Regulation of matrilysin gene expression. This table shows the results 
o f the experiment investigating the regulatory effect o f EGF (5 ng/ml) and TP A  (100 
ng/ml) on the matrilysin promoter. Significant absorbance readings from the CAT 
ELISA are highlighted with an arrow. All absorbance readings from  the CPRG assay 
were significant as they were all >0.3 (>0.15 ng)
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3.9.1. Discussion
As can be seen from figure 3.9.1. the CAT ELISA is very sensitive, detecting levels of 
CAT as low as 2-5 pg. This standard curve is linear in the range of 0-100 pg. Figure
3.9.2. illustrates the results obtained from the investigations into the stimulation 
conditions to be used. Sample 1 illustrates the amount of CAT protein expressed 
when the DOTAP transfection is carried out in serum-free media, which is 22 pg. It 
was decided to investigate carrying out the transfection in serum-free media as this 
would automatically eliminate the need to optimise an incubation time for the cells 
with serum-free media. The level of expression o f the transfected protein CAT is 
approximately doubled (43 pg) when a 24 hr stimulation w ith EGF (5 ng/ml) is 
administered (sample 2). W hen the transfection is carried out in the presence of 
serum, as were those in the initial DOTAP optimisation experiments on the A549 
cells, the level of CAT protein expressed was 41 pg (sample 3), practically the same 
as that obtained when the transfection is carried out in serum-free conditions and 
stimulated with EGF (5ng/ml) (sample 2). From this we could conclude that carrying 
out the transfection in serum-free conditions reduced the level o f CAT expression. 
Sample 5 is a duplicate sample of sample 3, and the result obtained is approximately 
at a similar level. Sample 4 and 6 investigate the use o f an 8 hr serum-free incubation, 
a 24 hr stimulation and a 24 hr serum-free incubation and a 8 hr stimulation 
respectively. As can be seen from  the graph, sample 4 resulted in the maxim um  
amount of CAT expression after stimulation with EGF (5ng/ml). Thus, the conditions 
o f an 8 hour serum-free incubation and a 24 hr stimulation were used in all of the 
stimulations. This experiment not only optimised the stimulation conditions it also 
demonstrated that the transfection conditions used are suitable for transcriptional 
regulation experiments. The results conclusively prove that firstly, the transfection 
conditions used are ensuring that a sufficient level of DNA is being transfected into 
the A549 cells to allow for expression of the CAT protein, and secondly, the induction 
of the CMV promoter by EGF (~ 2-fold induction) can be detected using the CAT 
ELISA.
As can be seen from  table 3.9.1. the absorbance readings obtained from  the matrilysin 
promoter constructs were not significant. W e also co-transfected the plasm id pC H l 10
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which codes for (3-galactosidase activity, to normalise for slight variations in 
transfection efficiency. All the absorbance readings obtained from  the CPRG assay 
were significant. These readings show that the A549 cells were successfully 
transfected in this experiment. W e have shown through these results obtained from  
the CPRG assay and the results obtained from transfecting in the pCM VCAT plasm id 
and stimulating with EGF, that the DOTAP transfection method and the CAT ELISA 
are suitable for use in transcriptional regulation experiments. W e concluded that the 
lack of significant absorbance readings in the CAT ELISA experim ent investigating 
the transcriptional regulation o f matrilysin gene expression, was due to a 
transcriptional inactivity of the matrilysin promoter constructs. Our collaborators in 
Nashville obtained similar results transfecting these matrilysin CAT promoter 
constructs into a breast cell line.
The inactivity of the matrilysin promoter constructs was thought to be due to the 
inclusion of 5’-flanking CAT promoter sequences when the matrilysin prom oter CAT 
reporter constructs were originally constructed. The presence o f CAT promoter 
sequences in this system would interfere with the transcriptional activity of the 
matrilysin promoter segments. The inactivity of the matrilysin promoter constructs 
also raises the possibility that the matrilysin promoter is a w eak promoter. Linking 
the matrilysin promoter segments to the more sensitive luciferase marker gene 
(Luehrsen el al., 1993) could help to alleviate this problem.
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4.1. Conclusions
The use of various transfection methods to transfect the SW 620, SW 480, W iD r and 
A549 cell lines were investigated. Table 3.8.2. summarises the results obtained. The 
SW 620 and W iDr colon carcinoma cell lines proved to be very resistant to 
transfection. The DOTAP transfection method was successful in transfecting the 
A549 cell line and this cell line was used in experiments investigating the 
transcriptional control of matrilysin gene expression. From  these experiments it was 
concluded that the human matrilysin CAT prom oter constructs w ere not 
transcriptionally active. Similar results were obtained when the human matrilysin 
CAT constructs were transfected into a breast cell line (personal communication from 
Lynn Matrisian).
Human matrilysin reporter promoter constructs linked to the more sensitive luciferase 
marker gene (Leuhrsen et al., 1993) have been synthesised. Future experiments that 
can be carried out with these human matrilysin luciferase prom oter constructs would 
include transfecting the promoter constructs into the A549 cell line and stimulating 
with EGF and TPA. From these experiments it would be possible to show if  EG F and 
TPA regulate human matrilysin gene expression and if  so, an approximate estim ation 
could be obtained of where in the promoter these factors affect transcription and 
through which czs-acting elements. These experiments would have narrowed down 
the area where these factors exert their effect to a few hundred base pairs. The next 
step would be to confine this area down further to the region o f 10-30 bp. This can be 
achieved by carrying out a time course digest on the matrilysin prom oter and 
subcloning the smaller fragments of interest obtained into the promoter reporter 
system. These will be transfected into the cell line of interest and stimulated with 
EGF and TPA to illustrate which of the smaller fragments produced the regulation 
expected. To conclusively prove that these factors are exhibiting their effect through 
the sequences found to be responsible, site directed mutagenesis will be carried out on 
the sequences in question. These mutated sequences will be subcloned into the 
promoter reporter system and transfected into the cell line o f interest. If the mutated 
promoter constructs did not show any regulation after stimulation with the regulatory
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factors than this would confirm that it is through this sequence that the factor of 
interest was exerting its effect.
There are two additional steps to fully elucidate the transcriptional control of 
matrilysin gene expression left to complete. The first o f these is to determine which 
transcription factors are binding to this region o f the prom oter that is the responsive 
unit for the particular growth factor or other regulatory factor in question. This can be 
achieved using the DNA electrophoretic mobility shift assay (EMSA) or gel shift 
assay. The method relies on the ability of a protein to bind to a radiolabelled DNA 
fragment in vitro, followed by electro-phoretic separation. It is based on the fact that 
during electrophoresis complexes of protein and DNA migrate more slowly through a 
nondenaturing polyacrlyamide gel than unbound DNA fragments or double-stranded 
oligonucleotides. One or more proteins binding to the DNA fragment may be 
identified. In general, the larger the protein, the greater the extent of retardation of 
mobility within the gel, (Fried et al., 1981). Various transcription factors and 
antibodies to these transcription factors are commercially available for use in these 
gel-shift experiments, to enable identification of the transcription factors. These 
antibodies can be used to determine what transcription factors are naturally present in 
the nuclear extracts from the cells in which the regulation experiments are being 
carried out, and aid in the purification of DNA binding proteins from crude cell 
extracts or from recombinant sources.
Addition o f antibodies which recognise protein(s) binding to the DNA to the reaction 
mixture to be electrophoreised produces an even slower migrating species than the 
original protein:DNA complex. This phenomenon is known as a “supershift” or shift- 
shift.
Competitors can also be analysed using this approach. Gutman et al., (1990) applied 
this technique to establish whether the putative PEA3 motifs in the collagenase and 
the c-fos promoters bound PEA3 and to what extent. The PEA3 collagenase and fos 
probes were competed with the PEA3 polyoma virus motif, which is known to bind 
PE A3. From the results of this assay it was concluded that the PE A3 polyoma virus 
sequence has a five-fold higher affinity for PEA3 than the PEA3 collagenase and 
PEA3 fos motifs. This approach which ascertained the binding affinity o f PE A3 to
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the PEA3 binding sites in the collagenase and fos promoters is an approach which can 
be applied to any promoter which has a PE A3 binding site.
The mobility shift assay does not allow the identification of the precise sequence to 
which a protein binds, as it employs relatively large fragments of a gene prom oter as a 
probe for DNA binding activity. So the last step in this process is to cany  out DNA 
footprinting which allows the determination o f a short protein binding site within a 
relatively large DNA fragment, providing an essential step in the characterisation of 
transcription factors.
The general principle o f in vitro DNA footprinting is based on the cleavage of the 
DNA molecule with either a chemical reagent or an enzyme. The DNA  of interest is 
radioactivity labelled at one end of the molecule and on one strand o f the DNA  duplex 
only. Thus limited degradation of DNA such that each molecule o f the DNA is 
cleaved randomly only once or a few times by the chemical or enzyme, resulting in a 
ladder of DNA fragments of varying size when the DNA is subjected to denaturing 
polyacrylamide electrophoresis and detected by autoradiography. Thus each band in 
the DNA ladder is representative of a specific nucleotide where the cleavage agent has 
cut the labelled strand o f the DNA. If M axam and Gilbert sequencing reactions o f the 
same DNA fragment are run alongside the cleavage products, then the specific 
nucleotide in the DNA sequence which is represented by each band can be 
determined.
If however, the DNA is complexed with a protein before being treated w ith the 
cleavage agent, the nucleotides to which the protein is bound will be protected against 
cleavage. Thus, certain bands in the DNA ladder, representative o f where the protein 
binds the DNA duplex, will not be produced due to the protein protecting these 
nucleotides against cleavage. This results in a gap in the DNA ladder which is 
representative of a protein binding a specific DNA sequence. By comparing the gap 
in the ladder to the M axam and Gilbert sequencing reactions, the precise DNA 
sequence protected from cleavage, and thus the DNA-binding site of the protein can 
be determined.
The information obtained at this point would give a clear picture as to what effect a 
particular growth factor has on the matrilysin promoter - where exactly in the 
promoter the factor exerts its effect, what transcription factors are binding to this area
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and what the precise sequence is that binds the particular transcription factor(s). This 
information could then be used to provide mechanisms through which the expression 
of matrilysin in a disease state could be controlled.
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